TSS:Hg 57442.1

Basic information about the TSS

---

TSS ID: hg_57442.1 Species: human Chr: chr5		Start: 86617919 End: 86617952 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000511472.5 ENST00000505430.5 ENST00000247655.4 AK026505 Distance: 0 GeneID: 1350 HGNC/MGI_ID: HGNC:2292 UniProt_ID: P15954

Gene_name: cytochrome c oxidase subunit 7C Gene_symbol: COX7C Gene_synonyms: Gene_source: HGNC:2292

TATA-Box annotation

---

Distance to TSS:	-5
Nearest PromoterID:	NM_001867
Entrez ID:	1350
Nearest Unigene:	Hs.430075
Nearest Refseq:	NM_001867
Nearest Ensembl:	ENSG00000127184
Gene Name:	cytochrome c oxidase subunit 7C
Gene Alias:	-
Gene Description:	cytochrome c oxidase subunit 7C
Gene Type:	protein-coding
CpG%:	0.06
GC%:	0.532338
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@COX7C p2@COX7C p3@COX7C p4@COX7C p5@COX7C
Sample		p1@COX7C	p2@COX7C	p3@COX7C	p4@COX7C	p5@COX7C
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	342.46	8.57	7.01	6.43	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	334.23	6.07	5.46	6.47	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	320.41	9.45	8.68	8.10	3.09
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	328.71	9.98	7.07	5.20	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	358.60	9.90	6.07	6.75	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	306.61	6.20	6.20	6.40	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	370.62	13.51	9.37	11.55	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	355.58	12.11	7.75	7.75	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	351.14	11.54	9.19	8.76	3.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	186.64	8.11	11.01	6.38	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	177.05	8.89	7.68	6.06	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	158.96	7.72	7.72	3.25	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	398.15	4.67	4.03	10.16	3.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	370.91	5.71	4.51	11.28	4.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	412.32	5.05	3.73	9.88	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	337.75	5.53	4.28	8.05	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	345.30	6.77	4.37	10.05	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	364.45	5.91	7.17	9.28	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	400.93	5.86	6.40	11.20	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	554.38	7.97	6.77	12.79	7.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	423.68	7.75	4.54	12.03	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	481.79	11.57	6.39	13.46	5.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	347.31	5.82	2.97	9.57	4.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	405.01	8.25	5.34	8.98	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	464.90	8.51	4.39	10.84	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	525.41	8.23	4.75	13.93	4.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	513.20	10.99	4.40	16.48	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	488.24	8.02	5.19	12.02	4.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	482.63	7.11	5.65	12.60	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	454.95	6.15	7.06	11.58	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	473.95	7.12	5.44	12.98	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	495.10	8.99	7.42	11.14	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	407.08	5.70	5.28	10.55	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	592.63	9.90	8.08	19.30	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	471.77	6.92	5.61	14.59	4.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	390.72	6.13	5.37	10.54	4.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	456.59	9.20	4.09	12.47	3.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	388.47	7.05	5.44	12.09	4.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	506.44	8.10	5.67	15.13	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	444.59	7.68	6.24	14.88	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	384.41	6.59	5.65	10.35	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	491.59	9.22	6.00	15.23	4.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	432.12	6.96	3.37	13.50	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	454.03	8.74	5.42	13.81	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	461.58	7.83	5.82	12.45	3.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	525.32	9.77	4.89	14.42	5.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	414.08	7.92	6.24	12.00	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	565.10	9.84	9.84	13.11	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	439.49	7.18	6.94	13.88	3.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	537.44	7.28	6.47	14.15	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	545.59	10.04	5.94	17.63	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	518.35	13.34	8.89	19.12	5.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	405.77	13.99	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	400.99	8.16	3.19	9.23	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	366.84	5.30	4.64	5.96	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	613.26	13.42	10.07	24.33	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	794.95	20.21	13.32	23.42	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	339.99	8.10	5.51	8.10	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	334.02	6.10	3.85	6.10	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	802.49	20.43	12.89	28.60	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	344.07	5.64	3.53	9.87	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	343.20	5.05	3.93	4.49	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	716.53	21.50	11.94	30.25	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	628.23	14.27	9.17	20.05	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	248.89	5.52	2.60	6.82	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	273.69	4.97	4.26	7.81	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	468.75	0.00	0.00	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	386.98	15.79	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	223.77	4.88	2.44	8.29	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	241.49	5.45	2.98	6.94	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	228.93	3.28	2.81	4.22	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	306.68	5.63	3.64	5.96	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	223.04	5.57	1.86	6.50	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	201.79	4.59	0.92	4.28	2.14
Adipocyte - breast, donor1	11376-118A8	169.63	2.22	0.79	7.13	1.43
Adipocyte - breast, donor2	11327-117E4	235.99	4.97	2.57	4.33	1.44
Adipocyte - omental, donor1	11473-119C6	178.88	4.20	0.76	4.96	1.02
Adipocyte - omental, donor2	11474-119C7	351.32	2.24	2.99	3.74	0.00
Adipocyte - omental, donor3	11475-119C8	460.85	4.69	4.02	5.36	0.00
Adipocyte - perirenal, donor1	11476-119C9	434.47	4.47	4.47	5.74	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	203.41	3.30	1.10	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	126.45	0.45	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	282.21	3.65	1.91	7.12	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	236.84	2.15	2.35	7.04	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	164.72	1.80	1.80	3.86	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	185.11	2.51	0.84	3.90	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	173.99	4.70	2.94	4.11	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	422.19	7.64	5.15	10.94	3.94
Adipocyte differentiation, day08, donor2	13023-139D8	242.07	5.16	4.20	3.55	2.26
Adipocyte differentiation, day08, donor3	13026-139E2	280.99	6.40	2.67	6.93	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	301.03	7.23	8.90	8.35	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	477.03	6.65	5.82	10.40	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	282.31	5.53	2.76	6.78	4.52
Adipocyte differentiation, day12, donor3	13027-139E3	290.92	7.53	3.93	10.80	3.27
Adipocyte differentiation, day12, donor4	13030-139E6	260.93	7.92	5.78	9.74	2.13
Alveolar Epithelial Cells, donor1	11510-119G7	287.30	6.41	3.76	9.28	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	365.39	13.27	9.32	10.40	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	285.13	5.99	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	276.16	2.52	2.52	4.32	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	366.50	1.67	3.35	6.69	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	236.26	3.90	2.26	7.81	1.64
Anulus Pulposus Cell, donor1	11248-116E6	296.25	3.09	2.06	9.50	2.17
Anulus Pulposus Cell, donor2	11463-119B5	398.71	3.43	2.94	8.33	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	354.94	3.15	0.90	4.04	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	315.62	3.47	2.17	3.91	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	346.72	4.28	2.14	8.56	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	318.65	2.69	2.09	7.17	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	369.28	1.26	1.26	6.32	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	285.81	3.96	0.66	4.62	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	298.90	2.60	1.30	4.55	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	334.95	1.46	1.46	6.80	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	274.97	3.56	5.94	11.28	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	325.04	3.39	1.13	3.01	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	304.78	3.63	2.18	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	279.59	5.02	3.76	3.76	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	193.57	1.48	0.99	2.47	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	307.08	2.73	1.36	9.55	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	401.41	4.98	2.41	7.39	1.96
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	291.47	4.29	2.14	5.36	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	260.92	2.27	0.57	4.72	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	249.11	1.60	0.53	6.95	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	256.54	2.93	1.95	1.95	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	259.24	2.16	1.33	6.47	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	285.77	1.20	1.20	9.61	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	251.35	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	224.36	1.72	2.40	3.09	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	226.53	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	384.46	0.97	0.97	3.88	2.91
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	307.73	1.52	3.04	7.97	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	251.96	1.21	3.63	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	369.38	2.85	0.00	6.27	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	264.65	3.21	1.07	4.06	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	245.44	4.90	2.32	8.26	1.81
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	329.85	2.82	2.35	5.63	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	251.45	3.22	0.64	4.18	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	281.81	0.71	2.14	9.27	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	289.55	3.51	1.75	2.34	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	255.01	2.71	0.60	4.22	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	331.45	3.56	8.32	4.75	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	384.98	3.56	5.09	6.61	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	307.41	3.82	1.78	5.35	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	276.39	5.08	4.45	5.08	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	307.25	3.45	2.59	6.04	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	282.18	2.12	1.69	5.72	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	287.66	2.61	1.45	6.67	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	273.03	2.83	0.94	3.78	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	255.98	2.37	1.53	6.10	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	266.38	0.00	4.63	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	280.97	6.34	4.23	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	280.02	3.00	2.14	4.72	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	247.28	6.62	1.80	6.62	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	370.32	4.37	1.46	5.10	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	309.88	5.98	2.30	7.13	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	239.73	5.10	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	424.57	3.81	3.05	9.41	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	255.57	3.30	3.10	7.84	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	256.12	3.06	2.14	6.73	2.14
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	343.69	2.87	3.35	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	268.75	2.88	2.00	7.10	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	292.95	4.58	0.00	4.58	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	320.70	3.32	1.66	2.77	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	263.74	2.65	2.38	5.56	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	294.03	2.91	1.82	4.36	1.82
Astrocyte - cerebellum, donor1	11500-119F6	361.94	10.93	7.61	18.18	0.00
Astrocyte - cerebellum, donor2	11580-120F5	384.08	10.27	8.22	14.38	0.00
Astrocyte - cerebellum, donor3	11661-122F5	320.07	10.28	7.13	16.99	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	334.29	13.94	7.32	11.50	4.88
Astrocyte - cerebral cortex, donor2	11316-117D2	222.60	11.49	7.44	12.62	2.59
Astrocyte - cerebral cortex, donor3	11392-118C6	256.70	6.71	5.67	10.59	1.79
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	310.45	9.86	5.28	13.53	4.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	306.69	8.77	5.51	15.66	4.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	285.74	11.15	5.12	15.82	4.44
Basophils, donor1	12241-129G9	278.79	2.35	2.88	4.97	1.57
Basophils, donor2	12242-129H1	366.93	3.61	4.33	8.66	1.44
Basophils, donor3	12243-129H2	188.74	1.76	1.18	4.56	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	362.00	3.23	2.59	4.31	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	263.80	5.94	5.94	8.69	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	573.89	14.35	0.00	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	296.25	8.79	6.90	4.39	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	70.50	3.12	1.66	2.29	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	115.84	2.99	1.84	2.76	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	394.80	4.50	4.68	4.68	3.24
Burkitt's lymphoma cell line:DAUDI	10422-106C8	385.12	24.63	18.55	30.71	5.26
Burkitt's lymphoma cell line:RAJI	10476-106I8	642.58	12.58	10.71	23.76	4.43
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	757.55	17.27	17.27	29.42	7.35
CD133+ stem cells - cord blood derived, pool1	12223-129E9	641.20	31.03	41.37	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	259.24	1.69	1.69	5.07	0.00
CD14+ Monocytes, donor2	11305-117B9	149.22	2.23	1.11	1.67	0.19
CD14+ Monocytes, donor3	11381-118B4	185.51	1.76	1.10	3.07	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	323.80	4.53	1.98	7.08	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	254.36	2.27	2.27	4.55	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	247.21	2.96	1.31	4.27	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	221.59	2.31	0.87	4.05	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	193.72	2.72	1.21	1.81	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	191.17	1.42	0.71	2.13	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	172.25	1.51	0.67	2.68	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	142.97	2.21	1.10	1.38	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	174.29	0.25	0.25	2.73	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	182.29	0.98	0.78	1.37	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	193.36	1.78	1.25	3.03	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	309.03	2.83	0.87	2.83	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	220.78	0.70	0.94	1.87	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	228.11	2.11	1.58	3.70	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	251.82	0.00	2.22	4.44	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	179.99	1.19	1.64	3.12	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	181.79	0.80	1.00	2.39	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	293.77	2.91	1.67	3.96	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	239.31	2.06	1.14	3.66	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	203.13	1.36	1.58	2.94	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	192.48	1.75	3.06	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	193.94	1.08	1.08	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	209.35	2.97	1.22	4.88	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	205.36	1.68	2.10	2.95	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	186.83	1.84	2.02	2.76	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	151.12	1.41	1.76	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	145.22	0.88	0.88	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	170.89	0.52	1.39	3.31	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	180.26	2.23	0.74	1.86	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	339.27	1.51	1.51	3.45	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	148.23	2.87	1.23	3.28	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	191.00	0.70	1.39	2.09	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	268.18	2.09	1.62	3.25	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	417.62	4.36	3.92	7.41	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	473.08	5.31	3.23	5.77	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	483.49	3.90	2.82	6.72	2.17
CD14+CD16- Monocytes, donor1	11788-124B6	352.87	2.65	1.87	6.07	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	371.82	2.97	1.40	5.41	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	257.75	2.01	1.34	4.01	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	832.63	7.91	5.61	10.46	4.34
CD14-CD16+ Monocytes, donor2	11800-124C9	572.19	6.81	2.85	8.34	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	572.68	4.42	3.37	7.16	2.32
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	981.61	10.16	12.19	12.19	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	908.49	9.49	4.07	10.85	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	968.28	4.14	2.07	8.28	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1005.84	8.53	4.80	11.73	4.80
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1029.79	8.58	6.43	8.58	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	963.76	2.81	2.81	8.42	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	916.91	6.27	4.71	8.63	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1265.55	11.86	7.91	10.55	2.64
CD19+ B Cells, donor1	11544-120B5	485.74	4.11	3.29	5.75	1.64
CD19+ B Cells, donor2	11624-122B4	442.51	2.90	4.35	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	407.39	2.52	6.06	2.02	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	351.13	10.91	6.06	18.99	3.23
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	404.68	11.98	9.99	19.58	2.00
CD34+ Progenitors, donor1	11545-120B6	608.45	10.04	18.07	20.08	4.02
CD34+ Progenitors, donor2	11625-122B5	650.57	6.18	8.43	17.42	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	441.14	8.64	11.65	22.55	5.64
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	665.85	12.85	13.75	28.64	7.67
CD4+ T Cells, donor1	11225-116C1	510.23	3.57	7.14	11.07	1.43
CD4+ T Cells, donor2	11306-117C1	541.33	12.25	12.25	11.63	0.00
CD4+ T Cells, donor3	11382-118B5	469.38	7.01	12.50	9.45	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	631.71	4.08	2.81	10.46	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	630.44	4.94	2.92	12.80	4.72
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	616.60	5.75	1.44	10.64	2.30
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1201.82	8.06	12.80	18.96	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1660.29	9.83	11.24	22.47	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1044.90	16.48	3.30	19.78	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	435.14	5.35	1.73	14.74	2.31
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	509.07	5.42	5.59	15.93	4.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	465.56	5.32	3.06	15.31	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	696.66	5.83	7.62	11.21	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	887.45	8.73	5.94	13.28	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	573.30	5.72	7.48	7.04	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	534.22	7.17	4.64	10.54	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	534.38	12.67	5.61	20.57	6.23
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	652.55	9.36	9.02	23.39	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	850.34	9.52	7.89	12.51	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1204.81	8.58	16.08	13.93	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	975.52	14.35	17.93	8.97	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	482.30	7.23	5.75	17.62	2.78
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	437.35	5.63	2.82	15.38	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	416.10	5.67	2.10	12.40	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1046.10	6.57	8.60	17.70	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1082.70	11.26	9.96	19.06	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	672.03	5.67	7.41	11.33	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1102.07	11.38	15.34	20.29	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1286.92	10.16	16.62	24.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1461.43	12.56	5.58	19.54	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1071.71	6.92	9.14	11.91	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1126.10	8.59	8.10	13.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	810.04	7.70	7.70	13.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	843.37	6.80	8.95	10.74	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1159.24	4.15	6.92	18.00	2.77
CD8+ T Cells, donor1	11226-116C2	401.39	3.60	4.91	11.46	0.98
CD8+ T Cells, donor2	11307-117C2	315.74	4.51	7.51	5.63	1.88
CD8+ T Cells, donor3	11383-118B6	458.02	4.54	11.36	5.30	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	183.05	4.59	2.98	3.21	2.75
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	150.26	2.64	3.83	5.51	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	169.90	4.65	4.65	5.20	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	229.96	6.60	3.00	4.20	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	161.99	2.40	1.92	6.00	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	158.72	2.96	2.05	4.55	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	186.86	3.48	2.61	5.65	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	180.82	3.68	3.16	5.26	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	186.91	4.69	3.75	6.10	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	196.22	4.23	2.72	5.13	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	205.10	3.20	3.20	5.23	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	180.64	2.93	3.20	4.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	108.12	0.00	1.75	2.63	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	124.33	1.82	2.73	2.28	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	117.10	0.75	0.00	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	195.20	2.52	2.16	4.32	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	172.35	3.45	2.30	3.16	2.01
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	158.15	3.77	2.12	4.95	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	183.49	1.58	1.27	4.12	2.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	184.85	2.15	2.46	3.69	3.38
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	170.87	3.21	4.17	3.85	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	173.64	4.97	4.21	4.59	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	183.26	1.97	3.55	5.12	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	160.36	3.78	4.54	4.54	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	122.05	0.80	1.61	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	121.70	2.10	2.10	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	114.20	2.00	2.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	122.46	1.83	0.00	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	276.20	5.43	4.94	4.94	0.99
Cardiac Myocyte, donor3	11686-122I3	289.71	3.79	1.89	6.10	1.47
Chondrocyte - de diff, donor1	11261-116G1	297.79	2.77	1.04	5.20	0.00
Chondrocyte - de diff, donor2	11338-117F6	213.94	1.78	0.71	4.98	2.13
Chondrocyte - de diff, donor3	11410-118E6	216.52	2.62	1.93	4.66	1.37
Chondrocyte - re diff, donor2	11339-117F7	174.57	4.48	0.90	1.79	0.90
Chondrocyte - re diff, donor3	11411-118E7	195.33	2.02	2.02	4.45	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	294.93	7.12	5.28	11.25	2.41
Ciliary Epithelial Cells, donor2	11323-117D9	270.84	13.25	5.34	17.96	2.78
Ciliary Epithelial Cells, donor3	11399-118D4	232.04	10.18	5.31	14.69	3.01
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	275.19	7.15	7.70	13.11	5.50
Corneal Epithelial Cells, donor1	11526-119I5	270.07	2.63	1.32	6.59	1.32
Corneal Epithelial Cells, donor2	11606-120I4	299.19	14.79	7.96	12.51	1.14
Corneal Epithelial Cells, donor3	11687-122I4	310.59	10.74	5.37	9.71	3.32
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	233.28	15.19	9.25	19.98	6.11
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	331.50	12.30	11.99	18.61	5.68
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	341.62	13.80	6.90	27.61	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	207.12	11.23	6.91	15.87	5.29
Dendritic Cells - plasmacytoid, donor1	11228-116C4	348.13	3.07	4.78	12.30	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	606.52	4.57	8.49	9.14	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	602.51	5.81	8.23	9.19	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	125.58	2.00	0.67	3.67	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	178.38	1.17	1.76	2.35	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	183.82	1.98	1.41	3.11	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	129.36	1.57	1.57	3.15	0.00
Endothelial Cells - Artery, donor1	11264-116G4	182.09	2.33	0.58	1.75	0.87
Endothelial Cells - Artery, donor2	11341-117F9	111.05	0.71	1.41	2.59	0.71
Endothelial Cells - Artery, donor3	11413-118E9	108.52	1.75	1.58	2.98	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	266.43	1.11	1.11	4.88	2.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	169.78	0.91	0.91	3.04	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	157.02	1.41	0.28	2.26	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	320.31	3.57	1.78	4.16	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	252.52	3.12	1.56	3.64	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	232.39	1.13	2.13	3.83	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	312.89	4.00	3.60	6.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	165.10	4.72	1.05	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	265.76	3.98	2.36	6.46	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	210.31	4.35	2.17	5.00	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	173.79	3.30	1.71	3.66	1.95
Endothelial Cells - Vein, donor1	11267-116G7	106.93	1.14	2.28	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	73.34	2.10	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	154.97	2.67	1.73	3.61	2.04
Eosinophils, donor1	12244-129H3	396.42	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	33.01	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	46.37	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	281.71	4.89	3.42	5.62	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	478.44	4.16	14.56	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	406.72	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	223.73	4.11	4.52	6.16	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	185.47	3.50	2.19	5.04	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	286.23	7.37	4.77	9.64	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	175.13	3.03	2.43	6.79	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	67.69	1.64	0.82	2.05	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	168.43	4.75	2.32	4.75	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	85.90	0.53	1.05	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	159.12	2.66	2.66	7.64	2.33
Fibroblast - Cardiac, donor1	11268-116G8	211.39	7.71	2.72	5.90	3.18
Fibroblast - Cardiac, donor2	11345-117G4	87.16	0.76	0.00	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	133.27	3.31	2.21	5.68	1.89
Fibroblast - Cardiac, donor4	11452-119A3	117.61	1.52	1.82	4.55	2.12
Fibroblast - Cardiac, donor5	11456-119A7	251.90	4.19	2.79	6.35	0.13
Fibroblast - Cardiac, donor6	11460-119B2	242.85	4.70	2.43	5.31	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	303.09	5.63	3.89	8.17	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	254.11	5.61	1.73	9.49	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	243.16	10.25	1.46	5.86	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	199.73	2.77	2.08	3.92	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	280.86	2.88	2.20	6.28	1.02
Fibroblast - Dermal, donor1	11269-116G9	236.19	2.35	1.17	3.05	2.82
Fibroblast - Dermal, donor2	11346-117G5	128.77	0.00	0.47	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	214.09	2.30	2.06	3.51	1.81
Fibroblast - Dermal, donor4	11450-119A1	263.40	3.17	2.37	5.09	0.00
Fibroblast - Dermal, donor5	11454-119A5	311.05	6.98	5.23	7.50	0.17
Fibroblast - Dermal, donor6	11458-119A9	337.03	5.68	3.09	6.82	0.00
Fibroblast - Gingival, donor1	11237-116D4	233.43	1.46	0.42	5.62	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	161.39	2.36	2.10	4.98	1.05
Fibroblast - Gingival, donor2	11318-117D4	266.60	4.88	2.90	6.72	2.24
Fibroblast - Gingival, donor3	11394-118C8	176.45	0.87	1.06	2.71	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	179.73	2.08	1.04	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	147.48	2.29	0.70	4.58	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	169.93	2.49	1.87	4.37	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	191.21	4.46	1.89	3.92	1.49
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	0.35	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	233.26	4.09	1.46	8.04	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	188.17	4.36	2.32	6.00	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	209.29	4.83	0.88	5.37	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	285.26	1.47	0.88	2.79	0.73
Fibroblast - Lung, donor1	11270-116H1	72.05	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	143.25	1.49	4.48	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	148.78	1.90	1.06	1.27	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	217.42	1.67	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	233.57	1.40	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	132.66	0.84	1.96	3.08	0.00
Fibroblast - Mammary, donor1	11540-120B1	180.25	2.84	2.03	2.44	0.81
Fibroblast - Mammary, donor2	11620-122A9	239.65	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	148.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	305.51	4.46	3.10	7.37	3.49
Fibroblast - Periodontal Ligament, donor2	11319-117D5	208.87	2.73	1.21	4.85	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	92.71	1.22	0.31	1.84	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	154.18	1.91	1.91	3.82	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	223.82	4.59	1.62	5.94	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	163.64	1.97	1.28	2.67	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	217.53	6.08	3.87	10.17	2.98
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	165.40	1.63	0.61	1.42	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	252.58	6.01	1.34	8.02	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	254.22	4.35	3.95	9.09	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	70.85	0.40	0.40	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	258.79	1.78	1.42	3.37	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	246.16	3.94	1.18	4.73	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	80.93	0.60	0.60	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	269.55	2.05	2.27	4.97	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	85.29	0.51	0.25	1.01	0.00
Fibroblast - skin normal, donor1	11553-120C5	213.14	2.95	2.13	3.45	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	55.74	0.80	0.20	1.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	211.37	2.01	1.21	3.01	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	85.84	0.60	0.60	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	237.19	2.07	1.41	4.72	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	421.91	3.42	1.88	4.44	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	83.09	0.66	0.99	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	235.63	2.45	1.70	4.79	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	214.06	3.20	2.36	5.06	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	365.70	6.27	3.76	9.57	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	332.40	0.00	0.00	44.32	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	196.09	8.72	6.10	19.17	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	183.76	4.68	2.08	6.24	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	167.07	3.12	0.78	4.68	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	131.33	1.79	0.51	5.62	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	675.22	123.25	104.88	71.96	13.01
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	920.10	185.68	144.84	91.88	10.85
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1354.15	291.54	163.17	191.98	24.53
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1083.73	55.43	58.74	64.80	14.89
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	487.71	44.75	40.41	53.43	9.59
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	903.47	154.34	104.61	110.36	15.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1058.93	54.72	58.15	61.59	14.27
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	417.14	30.33	32.61	45.99	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1466.41	341.40	252.51	210.06	12.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	515.40	42.26	33.35	32.36	5.09
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	401.20	23.77	18.47	19.83	2.83
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	387.63	52.11	30.35	36.53	8.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	286.32	9.04	8.30	11.15	2.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	353.40	18.41	13.43	14.67	2.63
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	317.15	24.60	17.28	18.50	5.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	289.10	9.36	4.79	11.87	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	328.36	8.47	8.22	9.09	1.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	253.77	8.74	4.59	9.40	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	382.94	11.82	8.86	15.36	2.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	337.31	12.24	10.49	13.67	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	281.73	11.17	5.59	8.71	4.69
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	298.62	12.50	10.48	11.29	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	310.95	16.46	10.52	15.61	2.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	213.79	11.97	6.12	15.07	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	215.50	4.68	3.75	7.28	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	233.62	3.24	3.24	5.81	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	338.60	9.96	6.53	12.50	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	238.36	10.23	5.91	13.15	2.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	269.72	7.96	7.76	12.05	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	352.37	9.49	10.52	12.58	4.95
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	328.24	6.57	7.96	11.07	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	254.98	6.34	3.67	15.51	3.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	306.84	5.95	4.85	9.70	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	453.96	8.12	5.29	9.47	2.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	251.57	11.99	5.67	12.97	2.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	421.42	7.70	5.45	8.98	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	281.42	9.38	6.06	9.29	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	259.88	5.54	4.75	7.91	2.85
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	277.33	10.64	6.39	11.86	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	265.53	9.20	7.32	10.56	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	322.75	7.46	4.83	15.37	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	267.08	10.10	7.57	7.86	3.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	166.93	6.20	4.81	9.91	1.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	206.44	8.02	7.49	17.11	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	163.56	5.51	2.30	8.87	2.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	202.34	9.72	4.27	9.33	2.72
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	242.07	9.22	4.61	10.57	2.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	219.19	7.93	6.08	13.46	3.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	239.71	6.80	3.51	9.21	3.73
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	163.64	1.98	2.98	8.93	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	168.32	6.07	3.56	7.39	2.77
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	192.27	3.63	3.43	6.05	2.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	100.39	1.02	1.52	3.30	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	779.32	58.92	44.79	43.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	535.11	37.29	30.82	31.59	5.55
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	627.25	69.35	41.73	46.85	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1091.19	174.93	113.91	134.87	19.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	991.20	165.01	102.85	127.72	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	762.83	122.22	111.15	83.48	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	722.64	108.89	47.02	49.50	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	654.09	97.09	73.49	67.30	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	803.84	142.80	70.60	109.10	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	483.39	33.04	38.25	27.82	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	645.10	64.44	51.75	44.27	8.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	561.70	65.48	44.06	50.65	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	449.86	13.33	19.99	13.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	542.52	40.55	33.28	39.99	9.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	491.25	39.55	29.42	29.42	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	443.74	27.68	14.26	20.13	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	535.63	27.99	28.31	25.76	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	593.39	33.97	29.55	38.72	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	954.28	48.03	37.59	48.03	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	713.58	19.47	22.34	38.94	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	562.37	22.49	19.24	27.23	6.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	709.85	30.49	22.02	44.05	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	549.65	41.01	23.61	40.18	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	511.81	32.68	32.68	35.67	6.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	879.84	52.68	31.61	42.15	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	517.03	31.14	21.14	43.44	3.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	602.07	24.12	22.17	34.88	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1031.35	34.78	24.08	36.12	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	728.16	16.18	14.64	23.50	9.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	568.97	18.83	21.23	24.31	5.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	854.77	24.85	7.45	12.42	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1195.67	16.51	27.37	25.95	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	803.25	14.48	24.14	24.14	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	936.47	14.24	23.40	26.45	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	930.09	20.74	21.54	31.91	7.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1037.03	14.80	21.71	22.20	6.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1494.44	14.17	17.71	23.61	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1172.14	17.50	19.84	26.26	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	987.05	9.22	13.61	10.09	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	869.73	7.63	19.50	16.95	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	660.19	30.44	30.44	42.98	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	726.42	36.39	31.54	43.19	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	125.54	2.28	0.00	2.28	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	122.25	4.16	0.83	3.33	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	95.58	0.00	1.12	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	294.64	0.95	0.63	4.76	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	354.25	2.92	3.76	6.27	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	342.32	14.04	7.08	22.16	4.87
Hep-2 cells mock treated, biol_rep2	11899-125E9	283.42	11.48	5.91	14.18	1.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	280.06	9.56	2.50	12.29	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	338.86	12.90	7.54	20.88	4.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	279.17	11.18	5.59	18.05	2.58
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	262.86	14.64	5.38	11.84	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	389.30	14.57	5.48	23.91	4.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	317.02	10.29	4.80	19.56	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	316.21	10.25	7.05	16.66	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	310.59	4.48	5.04	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	271.36	2.60	3.03	3.46	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	317.26	0.00	5.29	13.22	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	254.66	4.59	3.88	6.35	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	289.15	7.99	2.91	7.99	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	202.64	7.52	3.32	5.94	1.75
Hepatocyte, donor1	11523-119I2	295.39	6.05	6.05	6.05	2.42
Hepatocyte, donor2	11603-120I1	331.82	2.15	3.23	4.31	0.00
Hepatocyte, donor3	11684-122I1	247.87	3.68	1.23	4.91	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	494.74	39.16	41.77	45.04	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	292.93	14.86	7.34	14.51	3.32
Iris Pigment Epithelial Cells, donor1	11530-119I9	213.91	4.53	4.25	8.37	2.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	120.99	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	186.91	6.68	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	131.52	0.00	2.77	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	120.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	0.00	23.74	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	2.56	2.56	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	127.98	0.00	0.00	0.00	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	123.45	6.50	1.62	8.12	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	156.73	5.00	3.33	6.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	137.96	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	97.94	0.00	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	137.47	1.11	2.22	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	141.43	5.24	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	165.02	3.78	1.89	7.56	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	119.09	0.00	3.09	3.09	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	121.46	2.58	1.29	5.17	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	75.67	4.83	1.61	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	116.53	1.63	2.44	5.70	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	58.35	0.00	0.42	2.10	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	258.70	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	157.52	7.23	4.82	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	145.88	2.77	1.85	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	177.96	5.66	0.94	11.33	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	121.54	3.63	0.91	5.44	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	206.39	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	147.43	6.46	3.23	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	123.23	5.08	6.35	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	142.84	4.46	1.28	5.10	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	123.94	5.47	3.65	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	134.24	4.28	3.57	2.86	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	129.41	3.32	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	204.33	6.17	2.78	5.56	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	80.78	1.76	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	103.72	3.14	6.29	12.57	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	109.87	1.39	2.09	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	139.42	4.43	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	168.58	3.24	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	105.50	2.62	3.49	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	123.74	2.25	2.25	4.50	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	108.02	0.00	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	145.08	3.20	0.00	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	98.37	2.77	2.77	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	0.00	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	98.49	2.76	0.00	0.92	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	154.29	3.03	0.00	15.13	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	149.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	113.14	1.06	1.06	3.17	1.06
Keratinocyte - epidermal, donor1	11272-116H3	103.30	1.88	1.47	2.53	0.16
Keratinocyte - epidermal, donor2	11349-117G8	66.18	1.76	1.17	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	205.21	5.68	2.93	6.34	1.80
Keratinocyte - oral, donor1	11251-116E9	376.31	4.77	4.88	8.29	2.50
Keratocytes, donor1	11527-119I6	187.39	3.09	0.69	6.53	0.00
Keratocytes, donor2	11607-120I5	250.77	8.20	7.03	5.86	1.17
Keratocytes, donor3	11688-122I5	187.52	1.38	0.79	2.57	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	208.80	0.00	0.00	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	229.77	10.79	6.47	11.87	0.00
Lens Epithelial Cells, donor2	11609-120I7	317.74	5.77	4.04	7.96	3.81
Lens Epithelial Cells, donor3	11690-122I7	189.00	3.43	2.32	7.77	2.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	270.83	2.61	2.49	7.35	2.85
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	242.24	3.63	1.95	10.05	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	276.73	5.04	1.89	7.71	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	322.63	8.60	2.69	10.22	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	224.08	4.41	2.84	7.25	2.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	297.24	4.64	3.77	9.16	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	245.00	3.69	3.28	5.75	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	242.45	4.55	3.79	8.60	1.52
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	245.89	5.77	3.10	9.01	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	274.50	3.96	2.77	7.12	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	239.83	6.01	2.33	8.34	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	274.20	4.26	2.04	10.74	2.04
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	297.55	4.53	4.53	6.62	3.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	215.63	2.39	2.15	6.68	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	263.02	5.91	2.88	8.52	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	291.94	3.39	3.08	6.16	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	256.88	5.92	4.05	9.04	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	260.76	3.84	2.56	7.50	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	282.05	4.61	2.63	6.58	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	231.66	4.39	2.05	10.25	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	269.09	5.48	3.98	10.95	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	294.86	5.33	6.30	6.30	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	256.91	4.58	0.81	9.16	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	294.58	3.94	2.42	9.08	2.12
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	322.97	8.81	5.18	7.26	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	208.55	2.09	1.88	6.49	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	260.14	5.86	2.56	8.12	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	321.24	6.88	3.44	7.57	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	228.04	3.95	2.26	6.96	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	252.99	3.92	3.29	9.01	1.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	276.21	5.33	2.91	10.18	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	212.37	4.96	2.32	7.94	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	254.72	4.34	2.35	8.18	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	256.93	5.92	3.70	8.14	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	223.36	3.21	2.47	8.89	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	254.23	3.30	3.85	7.84	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	257.31	5.47	2.89	5.79	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	234.94	5.17	2.43	6.09	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	265.94	4.20	2.94	9.52	1.68
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	290.85	5.33	1.78	4.98	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	260.81	2.42	1.45	7.76	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	256.60	4.82	2.18	8.87	1.56
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	349.15	4.66	4.66	8.95	2.86
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	236.84	4.25	3.59	10.13	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	279.68	5.18	3.30	10.59	2.83
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	251.34	3.09	2.23	8.29	1.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	202.34	1.79	1.28	5.12	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	314.77	5.97	4.18	6.56	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	192.61	6.80	2.27	6.80	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	229.37	6.14	8.44	7.67	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	200.40	4.45	5.94	5.94	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	227.22	9.31	11.42	13.54	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	253.90	5.63	6.33	6.33	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	241.90	7.47	3.74	10.27	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	225.69	6.18	9.27	6.70	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	264.06	5.95	4.76	8.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	207.19	3.17	4.52	6.79	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	297.52	12.80	9.31	11.92	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	321.42	8.55	3.15	9.00	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	180.33	4.47	3.25	7.86	1.49
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	243.41	15.92	8.22	8.73	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	264.64	5.65	5.65	8.12	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	245.87	2.67	11.99	4.66	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	212.92	7.64	13.24	11.21	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	295.35	9.34	6.67	10.14	3.47
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	343.12	10.96	10.39	9.83	3.40
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	257.08	7.98	9.82	7.98	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	245.44	1.63	7.34	5.71	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	298.83	14.99	9.37	11.25	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	304.64	9.53	9.81	14.85	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	240.07	5.15	5.15	10.30	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	289.14	10.16	9.87	11.61	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	287.57	14.05	12.56	10.76	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	303.74	10.51	7.19	9.41	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	205.02	7.42	7.78	9.54	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	250.40	9.22	8.85	9.59	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	263.64	4.61	12.66	5.76	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	239.46	7.68	5.37	6.52	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	203.24	6.79	6.79	7.93	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	264.19	6.56	3.28	8.20	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	206.96	7.68	5.87	9.94	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	189.59	5.03	9.34	12.21	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	250.96	5.98	10.46	5.98	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	189.51	4.83	5.57	6.69	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	233.47	9.48	12.06	12.92	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	262.03	6.85	5.99	4.28	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	262.88	5.66	9.00	10.00	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	205.12	7.84	6.64	7.84	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	228.94	7.11	7.82	9.95	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	229.26	7.22	5.16	8.25	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	184.64	2.68	8.59	9.66	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	215.48	6.06	4.71	6.73	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	218.54	8.15	7.41	10.37	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	213.98	5.81	11.63	15.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	186.16	3.17	3.17	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	224.88	5.60	3.60	6.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	207.16	8.72	11.63	8.72	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	246.82	6.90	12.26	7.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	250.09	7.89	9.87	9.37	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	176.90	9.41	4.70	12.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	248.39	4.02	6.03	5.03	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	230.27	5.41	8.11	6.31	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	225.46	5.16	12.05	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	244.94	8.46	6.23	8.02	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	202.16	9.38	5.87	10.56	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	197.92	3.30	7.92	8.58	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	218.47	4.15	6.75	3.11	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	203.03	7.88	3.50	7.00	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	214.14	11.18	7.27	7.27	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	205.81	7.07	6.18	7.07	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	231.81	3.86	4.24	9.64	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	184.82	4.05	6.58	10.13	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	207.63	7.21	3.84	8.17	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	209.51	7.55	5.17	8.35	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	199.30	3.04	7.29	6.68	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	269.07	8.99	4.84	7.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	205.58	6.08	8.74	8.74	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	175.58	5.16	8.26	6.20	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	214.05	5.44	4.84	7.26	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	198.38	7.61	9.19	6.65	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	182.32	6.93	3.73	9.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	252.28	8.05	4.02	3.45	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	196.95	5.66	6.69	5.14	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	162.69	6.37	7.07	8.49	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	239.48	6.24	10.21	4.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	180.14	6.66	6.24	7.49	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	147.99	10.96	5.48	9.40	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	235.91	4.18	4.59	5.43	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	188.64	6.04	5.11	9.76	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	148.53	6.02	6.02	11.37	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	247.00	6.42	6.42	5.88	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	181.84	3.64	7.27	8.89	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	165.20	6.42	9.18	10.10	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	206.27	4.45	8.89	5.33	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	208.57	10.83	2.85	6.84	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	154.15	8.44	5.37	8.44	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	254.98	6.02	6.02	4.92	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	162.59	3.56	6.24	11.58	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	123.48	2.86	2.34	7.02	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	285.14	7.96	6.63	9.95	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	216.18	8.31	4.16	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	180.05	7.75	3.65	7.29	5.24
Macrophage - monocyte derived, donor2	11313-117C8	181.31	5.87	2.75	8.26	2.39
Macrophage - monocyte derived, donor3	11389-118C3	167.00	8.13	3.67	9.31	1.84
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	315.43	2.66	3.19	7.97	1.06
Mallassez-derived cells, donor2	11929-125I3	191.09	3.64	3.01	7.61	1.43
Mallassez-derived cells, donor3	11930-125I4	300.35	6.67	3.61	6.95	1.39
Mammary Epithelial Cell, donor1	11273-116H4	163.91	6.28	3.99	8.07	1.89
Mammary Epithelial Cell, donor2	11350-117G9	226.43	4.34	4.92	6.66	1.74
Mammary Epithelial Cell, donor3	11422-118F9	71.09	2.24	0.75	1.75	0.75
Mast cell - stimulated, donor1	11487-119E2	80.67	1.36	0.00	4.07	0.00
Mast cell, donor1	11563-120D6	235.42	4.00	3.24	9.08	2.70
Mast cell, donor2	11565-120D8	131.05	0.59	0.30	2.38	1.49
Mast cell, donor3	11566-120D9	157.14	0.90	1.80	2.25	1.13
Mast cell, donor4	11567-120E1	140.06	0.89	0.89	1.06	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	239.31	6.76	2.55	13.31	3.22
Mast cell, expanded and stimulated, donor8	11942-126A7	199.04	4.09	4.09	14.01	0.58
Mast cell, expanded, donor5	11939-126A4	232.43	3.10	1.84	6.42	1.49
Mast cell, expanded, donor8	11941-126A6	204.86	3.35	1.51	6.36	0.67
Melanocyte - dark, donor1	11502-119F8	277.50	2.69	1.79	6.67	3.88
Melanocyte - dark, donor2	11582-120F7	296.59	6.58	2.77	11.07	3.46
Melanocyte - dark, donor3	11663-122F7	183.57	2.68	1.38	4.71	1.88
Melanocyte - light, donor1	11274-116H5	84.63	0.00	0.24	1.65	0.47
Melanocyte - light, donor2	11351-117H1	81.90	2.05	0.00	2.05	0.00
Melanocyte - light, donor3	11423-118G1	95.39	0.87	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	211.58	2.60	0.94	3.12	1.77
Melanocyte, donor2 (MC+2)	12739-135I3	237.74	5.11	2.42	6.99	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	255.00	3.75	0.80	2.95	3.48
Meningeal Cells, donor1	11493-119E8	241.92	4.47	3.10	7.07	0.00
Meningeal Cells, donor2	11573-120E7	320.43	8.36	3.96	11.00	0.00
Meningeal Cells, donor3	11654-122E7	156.73	6.60	3.67	9.86	2.20
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	321.37	4.85	3.14	8.27	3.71
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	189.19	3.12	2.62	5.94	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	176.10	1.31	3.94	3.94	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	249.86	7.85	3.92	5.23	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	172.94	5.74	2.15	4.31	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	218.54	3.81	1.27	5.29	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	181.96	3.52	1.51	5.03	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	237.55	3.96	3.08	6.59	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	277.62	9.50	4.38	5.84	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	228.95	6.34	2.66	5.93	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	413.72	1.94	1.80	6.37	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	291.43	1.86	0.74	3.35	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	305.65	2.76	1.45	4.47	1.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	423.45	2.67	2.67	5.93	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	235.89	7.01	7.01	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	276.01	8.97	1.92	9.61	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	209.83	3.54	1.42	4.61	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	343.37	0.31	0.00	2.19	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	317.85	7.98	6.53	7.26	1.45
Mesothelial Cells, donor1	11247-116E5	343.14	5.83	3.18	11.14	2.65
Mesothelial Cells, donor2	12156-128G5	247.73	4.50	1.50	8.01	0.50
Mesothelial Cells, donor3	11402-118D7	182.61	3.04	1.73	5.78	1.59
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	101.27	1.35	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	290.11	8.13	4.43	10.10	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	186.98	6.48	4.42	10.01	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	294.76	8.68	3.41	10.23	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	158.27	7.88	3.32	13.28	3.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	266.53	9.01	5.01	10.76	2.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	124.28	3.26	2.33	7.45	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	234.31	7.11	3.86	11.38	2.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	138.59	4.75	2.77	5.94	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	272.56	5.31	2.65	8.85	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	233.66	14.44	4.56	13.30	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	250.85	6.58	3.18	8.06	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	62.62	4.60	3.68	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	150.52	4.77	2.68	5.96	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	1.68	0.00	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	273.23	8.03	5.27	11.54	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	135.23	5.47	4.52	8.32	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	39.81	1.11	0.00	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	231.86	7.14	6.45	6.45	2.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	155.23	5.26	2.73	9.04	2.31
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	137.99	4.28	2.45	6.11	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	234.92	7.08	2.79	6.01	3.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	98.92	2.45	2.00	8.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	163.82	3.72	2.63	6.35	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	62.36	0.00	2.53	3.04	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	0.00	0.00	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	144.05	2.72	4.35	4.35	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	107.34	3.82	2.94	5.29	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	27.26	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	224.42	6.25	0.96	11.05	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	139.68	9.21	3.20	9.61	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	35.65	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	205.24	2.00	4.00	4.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	269.47	53.89	26.95	107.79	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	223.34	5.69	5.69	7.88	3.07
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	46.35	0.00	2.21	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	35.22	0.64	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	194.37	5.95	2.23	7.44	3.47
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	59.85	0.00	2.09	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	0.00	0.00	2.21	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	176.07	2.74	4.10	7.18	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	62.58	1.31	0.44	2.63	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.42	0.36	1.07	2.49	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	174.50	6.73	2.81	7.86	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	83.54	1.66	2.08	3.33	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	28.55	0.00	1.17	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	81.75	2.41	0.90	1.51	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	135.23	7.10	5.01	5.01	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	96.05	1.85	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	126.91	2.85	3.41	3.41	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	73.37	2.07	0.97	2.63	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	125.95	3.89	3.37	4.92	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	121.83	3.86	2.14	3.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	19.06	0.00	0.00	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	70.99	1.87	3.47	3.47	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	152.66	5.99	4.79	6.59	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	63.42	1.84	1.13	3.53	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	146.52	6.05	2.87	4.46	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	138.65	5.53	3.10	5.75	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	42.09	0.76	0.38	1.90	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	137.22	5.97	2.84	6.25	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	194.92	10.57	4.92	8.36	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	36.49	0.00	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	112.32	1.76	2.94	4.41	2.35
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	181.07	8.07	3.75	6.63	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	97.27	2.89	2.89	9.48	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	106.90	4.47	1.79	4.17	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	508.53	7.53	3.77	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	401.01	7.13	8.91	7.13	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	328.90	6.90	2.30	7.23	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	390.27	8.42	3.16	6.31	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	369.28	4.74	2.57	12.26	4.15
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	294.30	2.79	0.93	4.66	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	359.01	7.89	6.76	10.89	3.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	285.25	7.46	2.66	10.65	4.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	213.42	4.64	1.47	5.66	1.92
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	254.17	4.42	2.21	8.10	5.16
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	241.47	4.76	1.83	6.96	5.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	281.56	3.11	1.56	6.22	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	490.61	8.55	7.48	10.69	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	386.39	3.86	3.86	15.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	229.26	6.06	2.02	8.08	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	335.62	9.28	5.90	10.96	3.79
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	619.68	8.17	6.81	17.71	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	780.76	15.26	9.54	17.80	2.54
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	793.64	14.58	11.34	20.25	4.86
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	566.41	36.25	7.55	22.66	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	505.68	19.57	16.31	22.84	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	166.34	14.26	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	214.57	4.96	3.66	7.97	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	226.81	6.79	2.61	7.32	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	87.44	0.67	1.33	3.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	60.52	0.83	0.83	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	323.81	5.51	1.71	5.13	2.47
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	295.23	3.19	7.98	9.58	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	76.15	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	152.52	3.68	0.00	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	129.33	1.67	1.67	1.67	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	139.46	1.16	0.46	6.04	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	127.01	0.81	0.27	1.35	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	174.08	1.89	1.05	5.05	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	0.00	0.00	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	165.78	0.50	0.99	4.47	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	277.71	2.71	2.17	12.45	2.71
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	155.50	1.81	1.36	2.95	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	135.38	1.14	0.98	1.47	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	273.20	2.00	2.37	4.56	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	177.70	3.18	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	122.46	0.00	1.20	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	578.58	7.88	3.61	17.07	2.63
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	140.51	0.98	1.14	2.44	1.14
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	246.58	1.41	1.59	4.06	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	212.38	1.41	2.11	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	187.10	0.46	0.46	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	201.80	2.57	0.64	3.21	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	552.86	8.28	7.59	17.59	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	204.80	2.53	2.53	10.11	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	177.34	1.11	1.56	3.56	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	170.20	0.42	1.27	6.35	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	195.10	1.66	0.71	2.37	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	215.91	2.58	3.00	3.43	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	189.60	1.00	0.67	1.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	157.80	4.06	0.45	5.86	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	145.23	2.38	2.38	3.17	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	137.44	0.93	0.93	0.93	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	284.54	1.89	2.65	6.43	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	111.78	0.98	0.33	1.63	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	113.74	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	239.71	2.71	3.62	4.52	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	133.17	3.53	0.00	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	166.88	1.33	0.66	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	176.10	1.49	0.99	1.98	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	82.69	1.15	0.77	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	272.81	1.21	0.91	2.12	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	209.31	2.87	2.43	3.32	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	175.51	0.68	0.68	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	168.61	0.00	0.00	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	217.05	3.05	1.22	6.10	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	107.01	1.26	0.63	1.89	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	150.12	0.91	1.21	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	208.07	2.37	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	368.43	4.53	4.53	10.20	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	298.42	5.06	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	174.17	3.73	1.86	6.21	0.99
Myoblast, donor2	11322-117D8	208.09	4.03	1.53	7.86	1.73
Myoblast, donor3	11398-118D3	132.85	2.35	1.18	3.87	1.51
NK T cell leukemia cell line:KHYG-1	10777-110G3	305.00	5.84	4.96	6.57	2.63
Natural Killer Cells, donor1	11230-116C6	323.82	3.69	4.61	5.84	2.15
Natural Killer Cells, donor2	11311-117C6	294.02	4.52	7.24	6.94	1.21
Natural Killer Cells, donor3	11387-118C1	245.90	3.87	4.97	4.60	0.18
Neural stem cells, donor1	11275-116H6	140.09	10.89	6.53	13.43	1.81
Neural stem cells, donor2	11352-117H2	171.38	3.85	5.78	7.70	3.85
Neurons, donor1	11494-119E9	384.61	14.79	11.38	9.10	6.83
Neurons, donor2	11574-120E8	233.59	6.83	6.83	13.65	1.98
Neurons, donor3	11655-122E8	553.32	26.31	18.91	32.89	9.04
Neutrophils, donor1	11233-116C9	23.20	0.00	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	20.29	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	32.99	0.00	0.00	1.83	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	378.41	4.39	3.44	9.38	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	285.55	3.91	2.28	10.09	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	468.69	3.61	2.81	9.02	0.00
Olfactory epithelial cells, donor1	11933-125I7	272.41	3.17	2.34	7.71	1.79
Olfactory epithelial cells, donor2	11934-125I8	316.85	8.97	2.61	11.29	4.34
Olfactory epithelial cells, donor3	11935-125I9	293.86	5.45	3.41	10.78	2.50
Olfactory epithelial cells, donor4	11936-126A1	300.28	1.85	1.46	2.82	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	290.08	4.81	2.41	9.03	3.61
Osteoblast - differentiated, donor1	11276-116H7	178.03	1.49	0.85	2.55	0.21
Osteoblast - differentiated, donor2	11353-117H3	208.05	3.43	3.43	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	202.35	3.10	2.48	2.48	0.00
Osteoblast, donor1	11277-116H8	90.88	1.95	0.78	3.13	0.39
Osteoblast, donor2	11354-117H4	171.37	3.51	4.21	7.73	1.40
Osteoblast, donor3	11426-118G4	140.76	2.49	1.24	4.09	1.96
Pancreatic stromal cells, donor1	11249-116E7	184.73	2.44	1.68	4.46	1.60
Pericytes, donor1	11491-119E6	458.31	9.01	4.56	15.35	0.00
Pericytes, donor2	11571-120E5	511.81	11.09	11.32	16.75	0.00
Pericytes, donor3	11652-122E5	277.71	5.49	3.05	4.88	1.22
Perineurial Cells, donor1	11499-119F5	245.93	3.84	2.71	5.99	2.26
Perineurial Cells, donor2	11579-120F4	238.31	4.32	1.38	7.27	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	308.54	1.91	2.23	3.82	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	234.33	2.20	1.96	5.39	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	208.88	2.33	1.42	4.79	0.52
Placental Epithelial Cells, donor1	11278-116H9	127.48	3.11	2.15	5.74	1.91
Placental Epithelial Cells, donor2	11355-117H5	135.28	2.22	3.33	8.87	1.11
Placental Epithelial Cells, donor3	11427-118G5	153.33	3.73	1.77	6.09	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	161.07	1.90	1.58	3.16	0.95
Preadipocyte - breast, donor1	11467-119B9	140.13	2.44	1.13	5.44	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.03	0.65	0.00	0.65	0.39
Preadipocyte - breast, donor2	11328-117E5	181.24	2.93	0.90	4.73	1.35
Preadipocyte - omental, donor1	11468-119C1	159.52	2.13	1.39	4.80	0.75
Preadipocyte - omental, donor2	11329-117E6	127.01	0.00	0.44	3.06	0.00
Preadipocyte - omental, donor3	11403-118D8	141.24	2.58	0.86	3.44	1.15
Preadipocyte - perirenal, donor1	11469-119C2	370.08	6.89	3.94	5.91	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	32.86	0.61	0.92	0.92	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	176.90	5.31	1.59	4.60	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	203.32	3.41	2.55	7.32	2.04
Preadipocyte - visceral, donor1	11280-116I2	170.65	5.68	2.51	5.59	0.84
Preadipocyte - visceral, donor2	11357-117H7	141.74	1.38	1.38	6.44	0.46
Preadipocyte - visceral, donor3	11429-118G7	243.36	5.64	3.45	6.16	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	279.23	13.88	8.60	16.29	4.83
Prostate Epithelial Cells, donor2	11331-117E8	162.50	4.06	3.25	5.28	0.54
Prostate Epithelial Cells, donor3	11404-118D9	176.42	3.92	2.82	2.76	0.92
Prostate Stromal Cells, donor1	11254-116F3	179.05	4.90	1.94	8.43	1.94
Prostate Stromal Cells, donor2	11332-117E9	202.43	6.81	3.05	9.50	1.43
Prostate Stromal Cells, donor3	11405-118E1	213.66	4.38	1.15	6.36	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	291.99	3.65	2.92	5.47	2.92
Renal Cortical Epithelial Cells, donor2	11596-120H3	255.14	4.85	2.63	6.52	1.87
Renal Epithelial Cells, donor1	11517-119H5	187.68	4.06	4.06	8.12	2.03
Renal Epithelial Cells, donor2	11597-120H4	304.44	7.11	4.98	10.67	3.56
Renal Epithelial Cells, donor3	11678-122H4	245.82	3.18	1.91	5.50	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	332.94	2.72	4.77	6.13	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	340.68	2.96	3.91	4.72	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	212.91	6.44	2.44	4.88	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	164.36	2.66	2.66	4.66	0.00
Renal Mesangial Cells, donor1	11518-119H6	275.99	4.18	1.98	7.26	1.32
Renal Mesangial Cells, donor2	11598-120H5	358.01	10.03	4.39	5.02	1.88
Renal Mesangial Cells, donor3	11679-122H5	254.39	7.49	3.61	10.82	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	276.48	4.56	1.88	5.10	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	316.27	5.90	2.53	4.64	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	250.89	7.14	2.51	8.29	2.51
Retinal Pigment Epithelial Cells, donor0	11215-116A9	446.74	12.19	5.19	16.85	4.15
Retinal Pigment Epithelial Cells, donor1	11528-119I7	399.08	5.40	6.25	13.36	2.56
Retinal Pigment Epithelial Cells, donor2	11608-120I6	268.60	15.44	10.29	15.44	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	194.45	7.53	7.03	14.05	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	302.28	4.14	2.67	5.35	4.28
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	276.96	12.51	8.93	15.19	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	432.04	11.56	14.86	19.26	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	287.71	5.22	6.38	10.44	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	240.16	6.63	4.16	13.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	203.48	9.53	3.48	11.52	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	194.52	9.48	3.79	15.84	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	295.60	10.42	5.33	17.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	228.89	12.12	5.36	17.83	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	249.16	11.56	5.08	17.57	2.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	245.48	7.12	4.52	11.36	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	209.97	9.08	5.14	12.25	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	194.96	8.96	3.58	15.05	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	289.49	7.46	6.46	12.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	204.97	8.05	5.04	15.13	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	261.76	10.18	5.53	18.81	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	245.47	5.16	6.50	8.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	186.05	5.40	3.17	12.30	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	150.70	10.52	3.95	16.91	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	214.19	4.91	3.45	8.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	177.45	7.69	3.60	10.22	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	215.97	8.78	5.92	14.32	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	232.49	5.98	4.70	9.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	191.17	8.13	3.36	12.61	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	189.18	7.69	3.08	11.96	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	234.29	6.02	3.10	10.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	185.42	8.09	4.29	11.90	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	225.79	11.82	4.70	15.98	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	318.43	8.49	6.60	10.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	203.37	6.75	4.17	16.87	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	273.83	12.16	4.91	19.18	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	311.86	9.33	9.95	10.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	213.69	9.73	6.64	17.70	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	200.32	9.82	5.64	13.16	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	257.33	7.40	5.92	11.71	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	160.25	6.81	3.24	10.22	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	192.02	9.45	4.63	13.30	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	281.81	8.25	6.53	10.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	174.89	7.68	3.57	10.15	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	224.26	12.48	7.55	14.61	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	257.52	7.67	4.60	10.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	183.91	8.73	5.62	11.84	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	159.13	8.53	4.26	11.20	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	271.69	5.67	4.98	8.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	235.96	6.90	4.52	12.14	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	199.53	6.45	4.23	10.48	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	284.69	6.69	6.50	10.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	239.31	8.04	5.24	15.02	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	203.09	8.46	6.04	11.18	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	264.72	8.08	7.10	13.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	221.97	7.13	6.26	15.28	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	305.43	10.95	7.30	15.82	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	328.52	8.44	7.53	11.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	154.71	6.56	4.98	9.95	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	194.40	4.79	3.59	8.69	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	205.10	5.43	5.90	8.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	170.76	6.62	4.91	9.39	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	257.22	10.22	9.01	12.62	2.40
Schwann Cells, donor1	11498-119F4	414.70	8.09	4.70	10.72	0.00
Schwann Cells, donor2	11578-120F3	197.34	0.00	0.00	13.61	0.00
Schwann Cells, donor3	11659-122F3	205.06	7.01	3.07	11.17	1.97
Sebocyte, donor1	11220-116B5	146.80	1.10	1.64	0.55	0.00
Sebocyte, donor2	11301-117B5	178.31	1.84	4.60	5.06	0.92
Sebocyte, donor3	11378-118B1	200.55	3.50	3.50	3.50	2.06
Sertoli Cells, donor1	11255-116F4	243.52	0.00	4.97	8.28	0.00
Sertoli Cells, donor2	11333-117F1	228.77	8.47	2.82	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	149.03	3.17	2.29	4.05	0.79
Skeletal Muscle Cells, donor2	11358-117H8	79.51	2.89	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	81.10	1.67	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	396.50	9.74	5.97	8.33	0.47
Skeletal Muscle Cells, donor5	11455-119A6	399.85	9.66	5.50	9.36	0.00
Skeletal Muscle Cells, donor6	11459-119B1	388.14	6.46	3.39	7.39	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	320.56	3.91	2.14	6.30	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	305.35	5.85	2.14	9.27	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	230.86	5.75	2.88	7.54	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	197.91	5.06	3.79	8.59	1.26
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	66.59	2.17	0.72	2.90	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	208.46	2.20	1.79	4.54	0.00
Skin - palm, donor1	10286-104F7	142.36	0.00	8.06	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	166.93	3.17	1.73	2.45	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	106.33	3.27	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	153.20	2.60	2.99	3.76	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	190.30	4.87	2.22	5.84	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	127.01	1.97	1.41	4.64	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	73.16	2.75	1.27	0.85	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	82.45	1.50	1.87	2.40	1.12
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	446.52	4.01	4.01	5.86	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	91.16	0.67	0.67	1.78	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	111.10	0.00	0.00	3.53	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	70.72	1.33	1.33	3.76	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	78.76	1.58	1.58	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	125.93	0.77	0.00	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	411.31	3.00	3.00	12.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	88.36	0.67	0.40	2.40	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	256.45	4.21	1.99	8.20	1.55
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	314.57	4.87	4.23	5.51	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	271.54	8.47	2.60	18.23	4.23
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	217.06	5.61	2.36	7.68	2.36
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	201.73	3.13	1.71	5.84	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	277.85	3.58	1.79	4.72	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	201.84	1.52	0.91	3.35	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	77.03	0.76	1.01	2.02	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	90.60	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	247.90	2.95	2.36	6.64	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	264.10	5.17	3.23	6.46	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	218.63	3.36	3.99	6.40	2.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	74.71	1.86	0.31	2.63	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	176.77	5.39	4.31	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	197.54	4.18	2.39	8.07	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	252.98	3.76	2.39	8.88	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	289.14	3.46	1.88	5.10	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	150.26	2.42	1.51	5.43	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	180.45	3.41	2.05	4.32	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	169.67	2.42	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	152.60	3.18	4.24	4.24	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	245.01	3.33	2.66	7.19	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	229.78	4.51	2.50	8.64	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	218.15	0.51	1.52	6.09	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	129.06	2.41	1.06	1.96	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	127.53	0.00	1.50	6.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	124.05	2.58	2.58	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	86.50	1.40	0.00	3.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	130.26	3.03	0.50	4.04	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	141.97	2.19	1.57	4.07	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	200.89	2.36	3.24	3.83	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	195.19	3.00	1.92	6.58	2.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	214.43	2.80	1.87	3.74	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	130.53	1.44	1.01	2.01	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	168.27	2.55	1.27	4.08	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	196.68	2.26	2.07	4.70	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	234.35	4.33	0.98	6.99	1.54
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	322.67	2.60	2.26	5.28	1.93
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	228.57	1.43	1.90	2.86	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	124.04	1.47	0.49	2.69	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	332.09	2.87	2.43	6.85	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	253.67	3.80	2.63	7.31	2.05
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	419.62	5.83	4.28	7.58	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	272.65	7.40	3.17	7.40	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	727.16	7.07	6.32	11.53	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	378.02	3.59	1.44	6.83	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	280.49	5.68	4.26	5.11	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	412.77	8.27	3.94	8.27	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	445.94	5.08	4.32	5.33	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	494.76	2.00	4.39	5.59	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	541.32	6.27	5.02	11.29	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	460.19	9.17	3.67	5.50	1.38
Synoviocyte, donor1	11291-117A4	204.51	3.70	1.68	6.06	0.67
Synoviocyte, donor2	11368-117I9	232.83	1.34	1.68	3.35	2.35
Synoviocyte, donor3	11440-118H9	328.19	1.56	2.23	2.68	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	253.71	4.29	3.22	8.22	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	152.62	0.00	1.98	5.95	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	155.37	4.40	2.08	5.33	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	204.09	4.44	2.94	6.74	1.65
Tracheal Epithelial Cells, donor2	11369-118A1	91.62	3.48	1.16	3.48	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	87.62	2.29	3.44	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	288.00	4.06	1.48	6.52	3.94
Urethra, donor2	10319-105A4	129.49	0.00	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	279.21	3.19	1.59	3.98	1.86
Urothelial Cells, donor2	11600-120H7	295.62	4.41	4.81	2.80	2.40
Urothelial Cells, donor3	11681-122H7	206.74	1.83	1.38	1.83	1.83
Urothelial cells, donor0	11216-116B1	309.16	1.11	1.11	3.79	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	487.60	0.89	3.56	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	591.86	0.00	5.72	5.72	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	279.28	2.74	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	367.41	4.82	2.75	6.54	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	347.45	2.91	0.58	4.65	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	458.15	2.08	6.25	6.25	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	602.99	0.92	0.92	3.67	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	303.08	0.91	1.83	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	255.60	8.39	5.30	9.50	2.71
Wilms' tumor cell line:HFWT	10597-108E3	118.81	6.16	3.52	10.56	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	273.45	7.82	3.63	9.50	1.96
achilles tendon, donor2	10292-104G4	157.06	4.13	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	376.32	31.36	17.08	36.20	10.45
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	427.20	24.84	12.31	30.41	6.73
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	272.32	14.24	12.70	22.20	4.39
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	337.69	20.41	16.87	35.10	5.17
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	168.09	11.24	4.50	9.56	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	155.02	4.44	4.23	10.36	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	284.73	15.52	8.17	14.97	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	622.18	11.46	6.17	7.05	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	371.20	11.43	9.80	15.11	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	422.86	11.65	6.21	15.92	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	303.97	11.59	6.26	14.90	2.94
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	499.27	0.00	7.80	19.50	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	345.78	20.45	12.08	20.22	3.95
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	359.61	17.35	9.84	16.83	4.40
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	315.33	10.81	8.48	12.27	3.51
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	218.44	6.51	8.83	6.51	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	332.29	12.75	9.46	13.16	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	270.73	4.91	2.15	4.91	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	518.02	14.08	8.11	21.34	9.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	438.26	13.65	2.43	11.53	7.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	484.54	14.92	8.18	16.85	7.70
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	258.82	11.36	5.57	6.01	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	325.21	17.01	6.34	11.67	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	340.05	7.43	11.15	24.16	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	268.56	10.55	6.78	9.79	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	227.23	15.26	10.03	22.24	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	258.68	5.62	9.37	28.12	0.00
adenocarcinoma cell line:IM95m	10796-110I4	509.39	12.48	11.07	26.61	8.24
adipose tissue, adult, pool1	10010-101C1	153.88	1.55	2.17	2.17	0.47
adipose, donor1	10184-103D4	1990.27	95.00	108.49	142.50	11.14
adipose, donor2	10185-103D5	529.20	25.55	15.82	30.01	0.81
adipose, donor3	10186-103D6	440.29	47.65	39.21	45.74	7.35
adipose, donor4	10187-103D7	644.86	110.08	64.14	90.14	7.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	168.24	4.10	3.47	6.63	1.58
adrenal gland, adult, pool1	10081-102A9	287.38	7.28	0.00	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	307.77	4.14	3.60	5.34	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	517.73	5.00	1.79	11.43	3.22
amniotic membrane cells, donor1	12235-129G3	210.06	4.17	3.01	5.56	3.01
amniotic membrane cells, donor2	12236-129G4	320.18	4.40	1.35	13.19	3.04
amniotic membrane cells, donor3	12237-129G5	334.37	5.01	2.65	6.78	0.00
amygdala - adult, donor10196	10167-103B5	417.40	16.60	16.60	10.67	4.74
amygdala, adult, donor10252	10151-102I7	272.72	10.95	10.75	9.73	4.66
amygdala, newborn, donor10223	10360-105E9	416.37	27.76	22.59	19.69	4.20
anaplastic carcinoma cell line:8305C	10428-106D5	309.79	1.02	1.53	2.80	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	578.47	36.62	22.06	33.09	7.06
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	427.57	8.35	5.01	9.02	3.67
aorta, adult, pool1	10052-101G7	310.67	4.71	4.71	5.10	2.16
appendix, adult	10189-103D9	261.98	5.82	3.88	7.37	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	609.11	12.73	11.01	22.01	4.47
artery, adult	10190-103E1	682.06	35.33	20.38	17.66	13.59
astrocytoma cell line:TM-31	10425-106D2	231.93	10.43	5.22	21.15	6.37
b cell line:RPMI1788	10427-106D4	433.32	7.14	6.25	11.30	2.08
basal cell carcinoma cell line:TE 354.T	10702-109G9	177.57	1.11	2.50	1.39	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	307.32	8.53	4.47	11.41	3.27
bile duct carcinoma cell line:TFK-1	10496-107C1	470.67	16.91	7.20	23.10	10.71
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	375.81	3.91	4.47	12.30	0.00
bladder, adult, pool1	10011-101C2	305.06	2.28	2.61	3.91	2.50
blood, adult, pool1	10053-101G8	476.14	0.00	4.43	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	241.49	3.43	2.57	7.71	3.43
bone marrow, adult	10192-103E3	209.87	5.40	3.37	10.80	1.35
brain, adult, donor1	10084-102B3	384.40	21.53	12.30	19.48	7.18
brain, adult, pool1	10012-101C3	256.79	11.02	9.24	12.14	3.67
brain, fetal, pool1	10085-102B4	504.89	16.03	8.01	16.03	5.34
breast carcinoma cell line:MCF7	10482-107A5	416.26	13.88	12.55	16.19	3.30
breast carcinoma cell line:MDA-MB-453	10419-106C5	257.76	4.74	2.25	3.62	2.87
breast, adult, donor1	10080-102A8	229.18	0.63	1.26	3.79	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	264.24	5.46	2.41	17.53	5.21
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	257.58	5.88	2.47	10.51	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	549.76	12.43	6.22	13.58	3.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	301.16	12.10	12.35	14.04	4.36
carcinoid cell line:NCI-H1770	10703-109H1	427.38	3.76	1.88	7.05	4.23
carcinoid cell line:NCI-H727	10735-110B6	186.17	6.34	5.58	9.30	2.52
carcinoid cell line:SK-PN-DW	10719-109I8	1000.12	44.68	38.98	36.76	9.51
carcinosarcoma cell line:JHUCS-1	10642-109A3	555.51	13.58	7.99	20.23	2.66
caudate nucleus - adult, donor10196	10177-103C6	453.62	24.18	11.51	14.97	5.76
caudate nucleus, adult, donor10252	10164-103B2	305.87	8.53	7.20	8.70	5.86
caudate nucleus, adult, donor10258	10379-105H1	583.80	34.39	25.22	29.80	3.82
caudate nucleus, newborn, donor10223	10354-105E3	539.46	30.03	26.74	27.10	5.49
cerebellum - adult, donor10196	10173-103C2	402.03	29.13	8.74	8.74	2.91
cerebellum, adult, donor10252	10166-103B4	194.51	7.05	6.62	7.47	2.14
cerebellum, adult, pool1	10083-102B2	344.94	14.14	11.38	13.45	4.83
cerebellum, newborn, donor10223	10357-105E6	386.91	38.19	29.06	22.42	2.49
cerebral meninges, adult	10188-103D8	315.93	14.62	11.35	16.64	3.28
cerebrospinal fluid, donor2	10294-104G6	366.17	16.08	10.96	15.35	3.65
cervical cancer cell line:D98-AH2	10552-107I3	328.54	5.32	6.04	14.67	4.03
cervical cancer cell line:ME-180	10553-107I4	429.70	13.75	7.79	18.73	7.62
cervix, adult, pool1	10013-101C4	261.22	2.73	2.10	4.62	1.36
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	360.75	3.48	1.11	4.04	2.51
chondrosarcoma cell line:SW 1353	10700-109G7	92.74	3.92	0.00	3.92	1.31
choriocarcinoma cell line:BeWo	10423-106C9	532.40	14.17	12.68	18.27	4.97
choriocarcinoma cell line:SCH	10785-110H2	280.31	5.54	5.05	6.04	2.59
choriocarcinoma cell line:T3M-3	10618-108G6	284.61	8.78	6.88	8.30	2.61
chorionic membrane cells, donor1	12238-129G6	184.63	2.28	1.71	3.42	2.28
chorionic membrane cells, donor2	12239-129G7	210.40	2.59	1.39	6.96	2.98
chorionic membrane cells, donor3	12240-129G8	252.76	4.95	3.85	5.49	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	661.42	92.90	74.73	43.42	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	422.23	18.25	14.41	22.28	4.61
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	307.91	13.73	9.50	19.85	4.22
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	339.23	12.07	6.16	11.56	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	358.71	11.37	5.32	11.61	4.11
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	303.38	10.79	6.92	10.99	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	467.30	16.78	9.72	29.15	5.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	283.56	7.30	9.12	18.50	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	238.64	13.26	9.37	18.74	3.66
clear cell carcinoma cell line:TEN	10636-108I6	404.44	7.11	3.30	9.20	3.82
colon carcinoma cell line:CACO-2	10513-107D9	259.00	16.29	9.15	29.65	5.67
colon carcinoma cell line:COLO-320	10420-106C6	421.51	6.84	4.18	10.64	8.36
colon, adult, donor1	10082-102B1	452.21	11.90	15.47	29.75	7.14
colon, adult, pool1	10014-101C5	319.96	9.05	6.35	14.34	2.70
colon, fetal, donor1	10070-101I7	448.04	5.56	8.03	9.27	5.56
common myeloid progenitor CMP, donor1	12130-128D6	41.25	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	901.32	25.04	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	145.33	4.67	1.70	5.10	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	195.61	6.34	2.41	10.11	3.02
cord blood derived cell line:COBL-a untreated	10449-106F8	230.84	7.05	3.38	8.46	2.54
corpus callosum, adult, pool1	10042-101F6	185.19	6.52	3.21	5.31	3.10
cruciate ligament, donor2	10295-104G7	176.68	1.62	0.00	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	619.58	27.29	16.85	32.10	11.24
diencephalon, adult	10193-103E4	314.14	14.88	11.28	8.88	2.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	481.27	26.63	17.68	28.24	3.21
ductal cell carcinoma cell line:KLM-1	10438-106E6	219.00	10.51	10.77	26.16	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	282.13	9.39	9.39	10.11	1.20
ductus deferens, adult	10196-103E7	272.59	5.98	4.98	13.46	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	473.84	12.96	14.40	15.84	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	427.41	16.18	15.45	20.60	0.74
dura mater, adult, donor1	10041-101F5	147.34	1.98	2.06	4.38	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	134.80	17.32	8.44	9.10	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	301.06	17.48	10.75	25.79	4.01
embryonic pancreas cell line:1B2C6	10604-108F1	156.62	1.85	3.08	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	238.23	1.82	1.82	1.82	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	195.44	3.70	0.62	1.23	0.00
embryonic pancreas cell line:2C6	10603-108E9	218.04	2.63	2.63	3.94	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	155.87	9.05	5.03	15.75	5.70
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	244.85	6.34	2.90	6.16	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	332.72	13.99	6.43	14.47	1.61
epidermoid carcinoma cell line:A431	10426-106D3	194.97	7.56	3.89	9.56	2.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	132.75	3.41	1.32	3.96	1.32
epididymis, adult	10197-103E8	237.36	4.60	5.65	9.21	2.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	208.46	1.95	1.06	3.90	1.95
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	190.72	2.75	1.97	7.47	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	290.80	11.27	3.41	14.28	4.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	239.26	6.89	3.25	12.89	5.61
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	308.53	7.28	3.36	15.46	7.17
esophagus, adult, pool1	10015-101C6	287.74	6.16	3.08	8.49	4.25
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	285.79	7.14	4.01	10.14	2.00
eye - muscle inferior rectus, donor1	10272-104E2	173.85	9.66	7.24	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	275.65	8.42	4.21	14.73	0.00
eye - muscle medial, donor2	10299-104H2	178.59	5.95	5.95	8.93	5.95
eye - muscle superior, donor2	10297-104G9	215.54	14.90	6.88	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	136.99	11.66	1.46	7.29	4.37
eye, fetal, donor1	10054-101G9	335.33	11.19	6.36	14.49	4.32
fibrosarcoma cell line:HT-1080	10758-110E2	322.23	9.62	6.67	17.31	4.10
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	344.50	10.68	9.26	11.16	4.27
frontal lobe, adult, pool1	10040-101F4	237.19	14.36	9.48	15.76	3.85
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	225.79	6.61	3.90	16.81	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	246.06	1.83	0.82	4.39	2.65
gall bladder, adult	10198-103E9	261.47	5.55	4.10	7.48	2.41
gamma delta positive T cells, donor1	11937-126A2	557.79	6.44	2.68	12.88	3.76
gamma delta positive T cells, donor2	11938-126A3	351.46	5.98	5.60	12.33	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	377.66	12.25	10.14	17.32	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	340.22	5.22	6.38	5.80	1.93
gastric cancer cell line:AZ521	10549-107H9	288.56	7.71	3.28	14.43	2.13
gastric cancer cell line:GSS	10560-108A2	329.48	5.49	3.66	7.32	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	241.48	14.62	11.88	15.08	0.91
giant cell carcinoma cell line:LU65	10487-107B1	331.49	2.52	3.33	5.74	2.64
giant cell carcinoma cell line:Lu99B	10433-106E1	517.57	2.80	1.26	3.08	2.24
glassy cell carcinoma cell line:HOKUG	10688-109F4	88.79	2.24	2.24	3.99	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	152.00	3.38	1.58	2.74	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	170.49	1.97	2.25	5.06	1.69
glioblastoma cell line:T98G	10485-107A8	251.76	5.63	3.86	10.71	3.09
glioma cell line:GI-1	10413-106B8	222.00	3.22	2.34	6.44	2.34
globus pallidus - adult, donor10196	10175-103C4	532.11	25.51	20.41	16.04	5.10
globus pallidus, adult, donor10252	10161-103A8	308.78	7.08	8.79	7.81	4.64
globus pallidus, adult, donor10258	10367-105F7	346.41	15.06	15.06	15.06	2.74
globus pallidus, newborn, donor10223	10364-105F4	457.24	24.51	20.25	17.59	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	0.00	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	469.92	32.79	21.86	32.79	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	736.95	26.13	26.13	62.72	5.23
granulosa cell tumor cell line:KGN	10624-108H3	161.60	3.52	3.20	4.16	1.60
hIPS +CCl2, biol_rep1	14383-156B9	1232.72	123.04	86.77	43.62	0.46
hIPS +CCl2, biol_rep2	14384-156C1	1037.53	81.39	78.65	25.15	0.00
hIPS +CCl2, biol_rep3	14385-156C2	1434.39	97.90	112.07	34.78	1.29
hIPS, biol_rep1	14380-156B6	1353.93	93.42	221.34	8.62	0.00
hIPS, biol_rep2	14381-156B7	1306.58	114.54	140.60	19.20	0.00
hIPS, biol_rep3	14382-156B8	748.15	32.00	33.10	14.35	0.00
hairy cell leukemia cell line:Mo	10712-109I1	327.86	7.76	2.30	5.75	2.30
heart - mitral valve, adult	10205-103F7	297.77	14.95	12.86	17.94	5.98
heart - pulmonic valve, adult	10206-103F8	374.96	27.45	16.21	25.89	8.37
heart - tricuspid valve, adult	10207-103F9	185.68	9.16	7.49	6.66	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	331.59	21.63	14.08	29.18	8.77
heart, adult, diseased, donor1	10051-101G6	551.88	43.01	18.74	56.64	8.09
heart, adult, pool1	10016-101C7	383.60	20.93	8.51	22.31	14.72
heart, fetal, pool1	10046-101G1	498.31	26.70	18.38	40.46	12.63
hepatic mesenchymal tumor cell line:LI90	10778-110G4	213.50	2.78	0.00	3.39	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	278.27	9.51	5.95	9.51	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	152.71	11.82	7.29	14.36	6.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	146.13	9.22	7.40	16.87	5.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	144.41	11.92	6.77	15.76	3.54
hepatoma cell line:Li-7	10484-107A7	243.45	10.57	4.23	19.13	6.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	335.87	23.42	16.08	28.74	6.53
hippocampus - adult, donor10196	10169-103B7	458.02	22.71	21.77	18.93	6.62
hippocampus, adult, donor10252	10153-102I9	250.43	7.14	9.80	7.35	5.10
hippocampus, adult, donor10258	10374-105G5	505.92	12.95	28.88	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	302.78	21.85	18.33	19.39	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1945.78	298.46	211.79	161.74	40.89
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	691.56	119.78	77.95	80.70	8.25
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	963.53	160.72	114.51	107.40	18.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	936.01	40.60	56.39	34.40	7.89
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	968.55	45.96	49.58	46.99	9.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	965.35	36.44	45.17	42.90	9.49
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	587.41	34.74	47.88	44.96	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	467.48	26.28	25.42	35.76	6.03
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	430.00	31.70	33.37	43.79	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	393.55	28.89	31.97	39.31	6.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	434.90	43.07	38.89	57.38	6.91
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	445.73	26.26	32.32	41.74	7.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	700.27	125.66	79.18	75.43	11.58
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1063.16	155.25	126.75	91.38	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2007.33	404.96	345.61	222.55	20.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	678.31	27.30	32.84	37.04	8.40
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	696.41	26.16	34.01	30.09	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1524.77	62.47	73.96	76.96	15.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	557.26	18.09	22.23	23.93	4.33
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	678.89	20.46	25.92	28.19	4.55
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	734.85	28.19	38.53	36.34	7.83
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	379.02	34.78	26.78	43.60	5.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	353.31	32.22	29.90	34.55	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	482.16	59.49	43.64	49.62	8.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	789.60	130.25	79.99	88.68	9.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	699.23	108.12	61.34	72.46	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1514.43	267.85	154.34	129.43	24.50
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	716.84	30.98	27.81	30.28	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	564.75	27.56	27.56	28.19	4.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	685.13	34.80	30.26	34.50	8.78
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	454.03	16.03	16.03	24.82	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	450.30	18.60	23.25	25.90	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	407.89	26.17	23.86	24.37	4.36
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	339.76	35.02	23.52	34.51	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	394.51	37.10	38.62	43.92	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	469.47	51.75	37.30	49.74	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	791.66	116.65	73.42	61.58	7.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1361.49	224.61	129.24	120.77	16.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1063.42	198.54	108.78	96.59	20.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	602.68	21.70	18.95	20.48	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	4323.56	117.12	172.42	221.22	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1271.15	38.72	57.58	55.60	11.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	548.94	16.42	24.63	25.18	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	597.47	24.97	35.46	31.85	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	540.21	23.13	27.76	21.00	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	380.69	36.99	38.19	41.77	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	343.71	21.40	19.37	35.89	5.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	533.94	60.88	52.53	50.11	9.43
immature langerhans cells, donor1	11904-125F5	174.83	3.87	7.99	11.14	1.94
immature langerhans cells, donor2	11905-125F6	194.86	6.34	5.54	15.84	1.58
insula, adult, pool1	10039-101F3	239.61	10.32	10.32	13.63	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	423.34	15.93	13.98	21.13	7.48
kidney, adult, pool1	10017-101C8	338.03	10.61	5.51	14.02	5.21
kidney, fetal, pool1	10045-101F9	225.51	6.37	4.31	9.34	2.48
large cell lung carcinoma cell line:IA-LM	10509-107D5	309.61	11.93	10.51	28.83	6.25
large cell lung carcinoma cell line:NCI-H460	10839-111E2	467.67	7.19	5.25	13.69	2.21
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	173.96	2.39	2.94	5.32	1.28
left atrium, adult, donor1	10079-102A7	790.03	35.42	28.88	49.58	10.90
left ventricle, adult, donor1	10078-102A6	625.49	44.50	18.20	48.04	18.20
leiomyoblastoma cell line:G-402	10721-110A1	236.13	7.11	3.01	8.21	2.74
leiomyoma cell line:10964C	10569-108B2	247.52	2.51	3.23	7.54	1.08
leiomyoma cell line:15242A	10570-108B3	220.65	2.72	2.17	8.15	1.09
leiomyoma cell line:15425	10571-108B4	198.87	1.94	3.16	6.07	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	190.48	0.00	0.00	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	169.38	0.00	0.00	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	388.29	23.38	18.77	28.10	6.49
liposarcoma cell line:KMLS-1	10782-110G8	205.88	5.31	3.91	7.81	1.41
liposarcoma cell line:SW 872	10726-110A6	295.95	7.31	4.87	15.96	6.09
liver, adult, pool1	10018-101C9	288.14	4.70	1.78	6.64	2.92
liver, fetal, pool1	10086-102B5	348.06	7.53	4.70	12.23	0.94
locus coeruleus - adult, donor10196	10182-103D2	290.48	17.35	14.29	9.33	2.77
locus coeruleus, adult, donor10252	10165-103B3	302.29	11.26	10.15	9.04	4.61
locus coeruleus, adult, donor10258	10375-105G6	393.58	18.62	18.62	12.98	1.97
locus coeruleus, newborn, donor10223	10362-105F2	409.26	27.76	23.55	18.93	5.47
lung adenocarcinoma cell line:A549	10499-107C4	224.20	8.72	2.49	14.39	3.74
lung adenocarcinoma cell line:PC-14	10408-106B3	255.77	1.38	0.00	6.89	4.83
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	247.42	5.27	3.56	10.41	2.24
lung, adult, pool1	10019-101D1	186.64	1.06	0.71	2.84	2.01
lung, fetal, donor1	10068-101I5	476.92	3.42	3.42	6.28	0.00
lung, right lower lobe, adult, donor1	10075-102A3	261.18	5.04	2.29	6.87	0.46
lymph node, adult, donor1	10077-102A5	314.79	3.79	1.42	4.73	1.89
lymphangiectasia cell line:DS-1	10727-110A7	412.49	8.55	7.01	19.07	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	338.83	14.49	5.13	17.81	3.17
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	125.73	3.40	5.10	1.70	1.70
mature adipocyte, donor1	12231-129F8	266.39	2.22	2.66	4.88	2.22
mature adipocyte, donor2	12232-129F9	298.63	2.49	1.66	5.60	1.04
mature adipocyte, donor3	12233-129G1	293.25	1.19	2.84	3.32	2.13
mature adipocyte, donor4	12234-129G2	428.78	6.05	1.84	8.42	2.90
maxillary sinus tumor cell line:HSQ-89	10414-106B9	233.49	5.00	2.86	11.20	2.38
medial frontal gyrus - adult, donor10196	10170-103B8	455.72	19.18	15.79	19.18	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	248.46	11.03	6.99	8.28	4.60
medial frontal gyrus, adult, donor10258	10368-105F8	715.75	46.06	39.39	27.00	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	770.24	54.59	44.35	41.80	6.82
medial temporal gyrus - adult, donor10196	10183-103D3	510.81	39.49	30.38	27.68	7.93
medial temporal gyrus, adult, donor10252	10156-103A3	245.33	8.91	7.85	8.91	3.18
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	541.28	40.45	30.82	9.63	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	488.02	43.06	0.00	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	402.00	30.15	23.33	20.82	4.31
medulla oblongata - adult, donor10196	10174-103C3	432.22	20.77	12.98	15.58	5.19
medulla oblongata, adult, donor10252	10155-103A2	219.67	6.50	5.26	4.95	2.94
medulla oblongata, adult, pool1	10038-101F2	186.27	6.12	6.69	7.84	1.80
medulla oblongata, newborn, donor10223	10361-105F1	291.28	24.30	15.28	12.15	3.12
medulloblastoma cell line:D283 Med	10838-111E1	467.84	11.51	9.52	14.17	1.11
medulloblastoma cell line:ONS-76	10759-110E3	232.07	13.21	7.95	15.53	3.30
melanoma cell line:COLO 679	10514-107E1	296.41	14.52	7.04	21.85	4.89
melanoma cell line:G-361	10465-106H6	217.44	2.44	4.34	8.42	2.71
meningioma cell line:HKBMM	10691-109F7	215.28	1.63	0.72	2.17	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	305.76	20.27	18.50	24.67	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	132.46	11.92	4.41	16.59	1.56
mesenchymal precursor cell - adipose, donor1	11747-123G1	285.54	5.68	1.99	7.98	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	218.68	3.09	1.27	5.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	290.70	4.56	3.73	7.04	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	242.74	1.12	1.12	3.09	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	301.75	1.93	1.93	6.16	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	208.92	0.69	0.00	2.78	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	317.52	4.81	2.75	5.84	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	216.00	2.53	1.73	5.98	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	211.29	5.17	1.86	6.50	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	210.66	3.38	2.30	6.08	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	186.79	1.42	0.57	2.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	229.89	1.98	1.65	5.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	211.43	2.49	0.97	4.84	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	183.62	1.75	2.79	4.89	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	244.79	1.84	1.63	4.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	176.49	1.80	1.08	3.59	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	222.83	1.14	2.38	2.59	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	181.94	3.19	2.05	5.70	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	244.60	2.52	3.36	7.55	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	205.93	3.14	2.24	4.33	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	231.08	2.19	0.96	5.25	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	240.41	1.10	1.47	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	162.25	2.00	0.29	3.15	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	271.98	7.16	2.11	8.84	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	228.79	2.28	1.37	4.11	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	206.16	3.33	0.77	5.88	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	189.51	3.40	1.57	5.24	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	174.38	4.31	0.62	5.85	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	192.05	3.06	1.88	5.18	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	188.18	3.72	1.02	3.72	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	172.51	3.14	1.18	3.54	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	183.96	1.39	1.85	2.78	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	227.56	2.31	2.31	5.19	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	178.26	2.90	1.12	4.69	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	186.27	2.88	1.20	4.57	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	184.07	4.40	1.47	4.40	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	166.49	3.02	2.01	7.38	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	180.95	4.91	1.23	8.19	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	192.87	3.44	3.01	5.58	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	259.77	5.47	2.73	10.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	170.44	10.33	0.00	15.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	258.53	5.20	3.25	8.12	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	256.08	4.36	2.91	7.27	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	332.64	6.40	2.67	6.40	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	282.95	2.45	1.64	4.91	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	262.77	5.05	1.94	7.00	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	279.13	6.30	2.10	14.69	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	250.35	8.94	3.97	5.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	243.13	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	261.50	2.37	2.37	5.34	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	261.97	14.62	2.44	7.31	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	270.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	249.55	3.80	2.53	4.43	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	304.21	2.41	1.38	8.62	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	303.04	0.00	4.30	10.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	315.35	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	371.94	3.44	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	334.13	4.07	3.26	6.11	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	384.51	3.97	3.97	6.36	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	384.96	1.77	1.18	2.95	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	417.37	2.49	3.74	4.36	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	422.39	5.35	0.00	2.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	447.05	8.28	4.73	5.91	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	508.46	12.84	7.70	15.41	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	399.96	8.95	5.51	7.57	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	677.39	9.90	14.35	17.32	8.41
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	628.04	14.58	7.85	15.70	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	703.49	19.08	5.72	13.99	8.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	759.22	18.13	10.07	20.55	11.28
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	963.82	23.99	10.90	19.63	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	691.81	16.47	15.20	15.20	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	529.81	6.07	4.86	9.10	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	650.73	27.11	9.04	31.63	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	626.00	9.88	4.94	8.24	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	656.20	7.14	6.75	12.30	4.56
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	552.94	12.01	8.44	12.33	6.81
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	520.52	7.13	7.13	11.20	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	165.57	0.77	0.00	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	323.65	3.54	1.65	3.31	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	383.42	7.88	4.87	10.43	6.26
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	269.24	29.92	8.55	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	575.30	29.28	15.93	34.22	5.55
mesothelioma cell line:Mero-25	10850-111F4	216.29	12.48	5.90	6.35	1.36
mesothelioma cell line:Mero-41	10851-111F5	232.74	2.93	1.47	5.13	0.24
mesothelioma cell line:Mero-48a	10852-111F6	140.39	5.09	1.99	5.76	0.22
mesothelioma cell line:Mero-82	10853-111F7	286.20	17.87	9.99	14.98	2.89
mesothelioma cell line:Mero-83	10854-111F8	264.69	8.34	5.45	9.36	1.36
mesothelioma cell line:Mero-84	10855-111F9	284.12	9.61	7.33	9.61	1.77
mesothelioma cell line:Mero-95	10856-111G1	225.47	9.11	3.52	8.49	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	160.35	4.64	2.32	3.64	1.16
mesothelioma cell line:NCI-H226	10846-111E9	318.73	15.02	13.03	17.56	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	255.72	7.86	3.59	7.86	1.71
mesothelioma cell line:NCI-H28	10845-111E8	482.72	13.49	9.67	12.98	1.27
mesothelioma cell line:No36	10857-111G2	340.23	13.70	7.50	10.44	1.96
mesothelioma cell line:ONE58	10858-111G3	234.92	5.96	1.90	5.96	0.81
migratory langerhans cells, donor1	11901-125F2	179.06	4.03	3.26	4.61	2.88
migratory langerhans cells, donor2	11902-125F3	107.22	0.98	1.34	4.15	1.34
migratory langerhans cells, donor3	11903-125F4	334.55	6.64	6.82	9.51	1.44
mixed mullerian tumor cell line:HTMMT	10689-109F5	344.44	6.20	1.96	7.18	5.22
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	222.53	41.54	16.53	27.76	5.93
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	219.76	8.52	4.61	10.60	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	253.09	6.47	3.43	5.33	4.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	530.35	9.05	5.54	14.04	5.73
myeloma cell line:PCM6	10474-106I6	273.57	5.14	2.57	11.86	2.77
myxofibrosarcoma cell line:MFH-ino	10600-108E6	118.71	11.67	8.12	13.19	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	217.52	4.32	2.55	5.88	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	259.06	3.45	3.23	4.79	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	373.07	4.93	4.63	6.84	2.65
nasal epithelial cells, donor2	12227-129F4	180.50	1.66	0.55	3.31	2.76
neuroblastoma cell line:CHP-134	10508-107D4	498.31	13.11	10.58	22.09	4.37
neuroblastoma cell line:NB-1	10539-107G8	322.72	6.74	6.74	18.71	5.24
neuroblastoma cell line:NBsusSR	10607-108F4	343.33	32.90	18.56	15.39	4.01
neuroblastoma cell line:NH-12	10555-107I6	523.65	8.57	14.72	16.40	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	659.72	19.93	18.74	32.74	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	607.39	30.88	29.93	23.92	4.43
neuroectodermal tumor cell line:TASK1	10774-110F9	483.83	16.91	17.31	32.00	4.83
neuroepithelioma cell line:SK-N-MC	10728-110A8	360.48	10.17	6.99	10.17	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	173.81	2.93	3.46	6.12	1.33
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	225.77	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	274.65	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	442.59	8.46	5.58	6.60	3.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	711.65	32.02	19.21	67.24	11.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	318.36	3.85	2.89	8.66	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	229.13	6.57	2.63	9.72	1.05
nucleus accumbens, adult, pool1	10037-101F1	247.66	9.94	10.22	13.78	3.28
occipital cortex - adult, donor10196	10172-103C1	416.20	30.91	20.60	10.30	4.12
occipital cortex, adult, donor10252	10163-103B1	261.12	6.17	4.56	6.71	4.03
occipital cortex, newborn, donor10223	10355-105E4	326.09	19.65	17.11	19.29	2.55
occipital lobe, adult, donor1	10076-102A4	374.18	24.14	16.79	18.11	4.99
occipital lobe, fetal, donor1	10073-102A1	570.27	15.88	12.44	21.88	4.29
occipital pole, adult, pool1	10036-101E9	167.14	7.17	6.78	9.62	1.97
olfactory region, adult	10195-103E6	248.94	14.52	12.42	9.93	3.25
optic nerve, donor1	10277-104E7	202.11	8.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	151.84	4.33	3.08	8.43	1.82
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	228.61	5.50	3.16	11.40	3.30
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	208.27	12.70	9.82	26.25	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	302.17	9.59	7.97	11.67	2.89
osteoclastoma cell line:Hs 706.T	10704-109H2	128.46	2.06	1.18	1.47	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	403.63	3.74	0.93	10.28	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	249.38	5.51	5.30	13.36	2.33
ovary, adult, pool1	10020-101D2	253.49	1.66	2.10	2.36	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	125.76	4.58	2.57	7.15	0.37
pancreas, adult, donor1	10049-101G4	444.92	11.29	16.93	26.34	9.41
pancreatic carcinoma cell line:NOR-P1	10698-109G5	371.22	8.95	4.75	11.46	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	257.91	2.21	1.53	5.45	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	172.54	1.32	1.49	4.64	1.99
paracentral gyrus, adult, pool1	10035-101E8	221.67	11.17	9.79	13.18	3.75
parietal cortex, adult, donor10258	10373-105G4	559.31	18.35	23.49	12.48	0.00
parietal lobe - adult, donor10196	10171-103B9	381.84	15.05	15.05	13.17	1.88
parietal lobe, adult, donor10252	10157-103A4	260.81	11.40	7.13	8.27	2.00
parietal lobe, adult, pool1	10034-101E7	229.20	8.64	8.11	14.28	4.49
parietal lobe, fetal, donor1	10072-101I9	667.25	27.16	15.52	24.25	2.91
parietal lobe, newborn, donor10223	10356-105E5	351.43	23.93	18.69	16.82	3.36
parotid gland, adult	10199-103F1	434.75	12.95	8.63	15.42	1.85
penis, adult	10200-103F2	322.80	16.11	9.13	8.59	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	299.54	5.39	4.09	4.28	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	309.02	10.64	6.99	13.11	5.83
pineal gland - adult, donor10196	10179-103C8	142.55	5.81	3.23	8.39	5.81
pineal gland, adult, donor10252	10160-103A7	239.85	10.66	7.11	15.99	4.15
pineal gland, adult, donor10258	10377-105G8	229.51	21.95	9.41	25.08	3.76
pituitary gland - adult, donor10196	10180-103C9	649.58	11.13	13.15	20.24	5.06
pituitary gland, adult, donor10252	10162-103A9	483.13	8.86	5.21	14.59	4.69
pituitary gland, adult, donor10258	10378-105G9	638.43	16.17	15.32	34.05	5.96
placenta, adult, pool1	10021-101D3	134.16	1.94	1.29	5.38	1.94
plasma cell leukemia cell line:ARH-77	10840-111E3	489.32	13.24	6.36	11.79	2.65
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	224.43	3.42	3.58	8.40	2.49
pons, adult, pool1	10033-101E6	178.59	9.30	8.09	9.73	2.50
postcentral gyrus, adult, pool1	10032-101E5	251.07	11.94	10.72	16.13	3.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	25.10	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	545.30	5.51	22.03	44.06	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	774.56	0.00	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	330.22	6.70	5.24	9.61	7.87
prostate cancer cell line:PC-3	10439-106E7	748.51	16.52	14.52	35.39	15.61
prostate, adult, pool1	10022-101D4	267.90	2.54	1.81	4.35	1.27
putamen, adult, donor10196	10176-103C5	366.84	16.29	15.58	17.70	7.55
putamen, adult, donor10252	10152-102I8	815.66	21.57	21.57	13.73	11.76
putamen, adult, donor10258, tech_rep1	10372-105G3	886.27	40.43	63.38	21.86	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	471.39	20.54	19.09	14.50	1.69
putamen, newborn, donor10223	10365-105F5	673.95	32.24	31.49	23.99	3.75
rectal cancer cell line:TT1TKB	10469-106I1	143.43	4.36	6.11	9.60	3.20
rectum, fetal, donor1	10067-101I4	534.14	5.56	8.35	16.69	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	239.56	6.15	1.27	10.60	2.54
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	207.11	0.00	0.83	1.66	2.07
retina, adult, pool1	10030-101E3	264.80	7.55	4.08	12.23	4.27
retinoblastoma cell line:Y79	10475-106I7	485.31	7.27	7.01	21.04	4.16
rhabdomyosarcoma cell line:KYM-1	10787-110H4	306.14	17.34	8.61	15.37	3.93
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	303.42	14.62	11.81	32.62	3.94
sacrococcigeal teratoma cell line:HTST	10695-109G2	269.80	1.52	0.76	3.03	0.76
salivary acinar cells, donor1	11771-123I7	261.07	4.69	4.05	5.99	1.29
salivary acinar cells, donor2	11772-123I8	263.95	5.37	5.51	12.67	0.69
salivary acinar cells, donor3	11773-123I9	192.66	0.66	2.65	5.30	0.00
salivary gland, adult, pool1	10093-102C3	956.30	15.44	20.02	25.17	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	143.50	1.18	1.52	3.46	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	177.86	0.94	1.41	5.88	1.29
seminal vesicle, adult	10201-103F3	283.58	4.76	3.70	14.81	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	300.98	7.77	11.17	28.42	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	304.22	1.76	1.51	4.78	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	368.30	12.04	8.03	16.06	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	206.72	7.39	7.52	9.27	1.61
signet ring carcinoma cell line:Kato III	10436-106E4	185.47	7.29	3.76	8.73	2.76
signet ring carcinoma cell line:NUGC-4	10483-107A6	492.62	18.58	16.13	23.48	4.77
skeletal muscle - soleus muscle, donor1	10282-104F3	512.85	19.15	21.28	18.44	4.97
skeletal muscle, adult, pool1	10023-101D5	479.15	9.95	7.08	12.35	5.52
skeletal muscle, fetal, donor1	10066-101I3	613.06	7.04	5.03	7.04	2.01
skin, adult, donor1	10074-102A2	305.33	13.57	0.00	13.57	0.00
skin, fetal, donor1	10065-101I2	376.84	10.73	14.52	12.62	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	375.21	17.68	6.00	25.35	10.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	192.28	7.25	5.04	9.46	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	496.33	4.63	2.70	7.13	2.31
small cell lung carcinoma cell line:LK-2	10541-107H1	280.37	11.87	7.75	21.76	2.97
small cell lung carcinoma cell line:NCI-H82	10842-111E5	501.53	3.22	3.22	5.63	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	130.75	6.97	3.49	9.15	3.05
small intestine, adult, pool1	10024-101D6	376.72	14.33	7.41	23.65	6.81
small intestine, fetal, donor1	10064-101I1	491.15	12.28	15.97	31.94	5.90
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	182.59	7.69	7.18	8.72	0.00
smooth muscle, adult, pool1	10048-101G3	366.49	5.69	8.53	6.72	2.84
somatostatinoma cell line:QGP-1	10781-110G7	354.06	9.38	8.58	18.76	6.70
spinal cord - adult, donor10196	10181-103D1	322.54	11.93	9.18	8.95	3.90
spinal cord, adult, donor10252	10159-103A6	244.05	1.58	0.79	4.73	2.37
spinal cord, adult, donor10258	10369-105F9	739.53	17.29	19.37	11.07	0.00
spinal cord, fetal, donor1	10056-101H2	310.41	15.86	8.54	22.56	3.05
spinal cord, newborn, donor10223	10359-105E8	516.61	15.15	15.61	13.78	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	123.37	2.69	0.90	2.54	0.90
spleen, adult, pool1	10025-101D7	167.84	2.75	1.98	4.19	2.20
spleen, fetal, pool1	10044-101F8	156.77	2.30	1.59	3.02	1.19
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	249.88	7.04	6.11	15.84	2.17
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	210.95	4.94	4.56	9.11	3.99
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	299.83	23.06	18.17	32.15	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	261.92	6.65	6.65	10.56	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	167.83	6.42	6.08	21.05	3.49
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	249.50	17.37	10.59	23.72	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	138.34	4.65	0.42	9.31	1.69
stomach, fetal, donor1	10062-101H8	374.86	11.75	9.61	12.82	2.14
submaxillary gland, adult	10202-103F4	439.79	11.96	11.96	11.96	6.27
substantia nigra - adult, donor10196	10178-103C7	597.02	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	264.20	5.61	4.36	4.98	3.53
substantia nigra, adult, donor10258	10371-105G2	666.74	19.66	44.48	4.14	0.00
substantia nigra, newborn, donor10223	10358-105E7	372.37	19.78	23.32	14.13	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	220.09	6.88	5.50	12.61	4.81
temporal lobe, adult, pool1	10031-101E4	226.17	10.85	9.41	14.50	3.56
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	530.64	6.41	12.11	22.08	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	401.30	11.43	11.43	20.66	0.44
tenocyte, donor1	11763-123H8	188.17	1.05	1.40	3.84	0.70
tenocyte, donor2	11765-123I1	235.77	1.53	1.91	3.05	1.53
tenocyte, donor3	11768-123I4	205.35	0.74	1.85	3.71	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	241.85	25.32	15.98	27.36	3.23
teratocarcinoma cell line:NCR-G1	10798-110I6	182.36	16.96	15.88	27.13	3.70
teratocarcinoma cell line:PA-1	10807-111A6	286.71	27.43	16.74	20.61	3.87
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	346.57	26.66	13.71	23.36	4.82
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	314.64	15.13	15.13	14.75	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	481.18	6.11	9.71	11.12	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	314.30	21.17	10.42	21.82	3.91
testis, adult, pool1	10026-101D8	242.77	1.93	1.29	4.72	1.50
testis, adult, pool2	10096-102C6	306.29	5.41	4.06	8.12	1.80
thalamus - adult, donor10196	10168-103B6	450.43	33.12	18.77	11.04	7.73
thalamus, adult, donor10252	10154-103A1	245.05	7.50	7.50	6.25	4.69
thalamus, adult, donor10258, tech_rep1	10370-105G1	735.94	24.63	80.06	4.62	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	292.82	25.03	16.96	16.96	2.96
thalamus, newborn, donor10223	10366-105F6	413.65	54.08	32.79	25.31	2.88
throat, adult	10209-103G2	364.27	17.73	7.74	11.73	5.99
throat, fetal, donor1	10061-101H7	428.11	12.80	7.31	13.71	5.79
thymic carcinoma cell line:Ty-82	10803-111A2	254.58	7.95	8.94	17.29	1.59
thymus, adult, pool1	10027-101D9	254.70	3.78	4.18	6.06	1.49
thymus, fetal, pool1	10043-101F7	265.79	4.57	3.12	7.79	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	505.65	19.28	8.11	21.54	3.19
thyroid carcinoma cell line:TCO-1	10783-110G9	562.39	5.03	3.91	7.82	3.77
thyroid, adult, pool1	10028-101E1	388.65	4.48	3.36	4.85	2.24
thyroid, fetal, donor1	10060-101H6	360.43	14.77	10.55	15.29	6.86
tongue epidermis (fungiform papillae), donor1	10288-104F9	117.03	9.24	3.08	9.24	3.08
tongue, adult	10203-103F5	409.10	19.77	14.42	22.09	5.81
tongue, fetal, donor1	10059-101H5	862.28	67.00	30.74	55.57	29.16
tonsil, adult, pool1	10047-101G2	245.23	5.11	2.10	9.02	2.30
trachea, adult, pool1	10029-101E2	207.52	2.62	2.13	4.83	1.80
trachea, fetal, donor1	10058-101H4	347.76	13.85	12.31	17.70	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	212.92	2.48	2.83	4.96	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	250.25	7.80	3.04	15.20	2.84
transitional-cell carcinoma cell line:JMSU1	10492-107B6	460.97	7.83	6.11	17.08	4.07
tridermal teratoma cell line:HGRT	10694-109G1	205.47	0.00	1.90	7.61	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	257.59	6.60	4.83	13.12	4.32
umbilical cord, fetal, donor1	10057-101H3	302.54	12.52	6.26	22.95	6.26
uterus, adult, pool1	10100-102D1	402.85	2.22	2.90	3.41	0.00
uterus, fetal, donor1	10055-101H1	320.98	4.61	5.12	10.24	3.07
vagina, adult	10204-103F6	317.28	1.29	1.29	1.29	0.65
vein, adult	10191-103E2	247.04	3.95	3.95	6.80	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	519.39	8.55	6.94	6.14	1.60